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SUMMARY 
Anion exchangers play a key role in the maintenance of many physiological processes in the body 
by transporting different anions such as Cl-, HCO3-, SO42- and oxalate across cell membranes. They 
participate in the CO2 metabolism, contribute to the regulation of the cell growth, shape, death, 
metabolism and contractility, and regulate intracellular pH, cell volume as well as ion gradients.  
Two structurally different groups of anion exchangers have been found in human.  A classical anion 
exchanger (AE) gene family consists of at least three members, which facilitate a Na+-independent 
electroneutral exchange of Cl- for HCO3- across the plasma membranes of mammalian cells.  AE1 
(band 3), which has been recently renamed as solute carrier family 4A member 1, SLC4A1, was the 
first anion exchanger identified, followed by its homologs, SLC4A2 (AE2) and SLC4A3 (AE3). 
The AE anion exchangers form a subfamily of the larger SLC4 family of bicarbonate and anion 
transporters.  
 
We have focused our attention on the clearly distinguishable group of the previously so-called 
sulfate transporters, recently redefined functionally as the second anion exchanger gene family 
SLC26. Interestingly, the first three human genes, SLC26A2, SLC26A3 and SLC26A4 associate 
with phenotypically different disorders, involving cartilage growth, gut absorption, and hearing, 
respectively. SLC26 family is well conserved across taxonomic span, and our observation that the 
first fully sequenced animal, C. elegans, has seven putative members of this gene family prompted 
us to hypothesize that many more than three genes with important physiological functions or 
disease associations might exist also in human, stimulating the current study.  By a genome-driven 
approach, we identified and mapped seven novel loci (designated SLC26A1, A6-A11) with distinct 
tissue expression patterns. Subsequently, we have systematically characterized the structure, 
expression and function of the SLC26A6-A9 genes using different molecular biological and 
physiological protocols. 
 
The first new member, named SLC26A6, maps to chromosome 3p21.3 and encodes a predicted 738 
amino acid transmembrane protein. The SLC26A6 protein is structurally highly homologous to the 
previous tissue-specific anion transporters. It is expressed at highest levels in the kidney and 
pancreas, and more specifically, in a subgroup of tubular cells in the kidney and in two pancreatic 
ductal cell lines. We identified also two alternatively spliced variants of SLC26A6, named 
SLC26A6c and SLC26A6d with tissue-specific expression patterns. Functional expression of the 
three variants in Xenopus oocytes demonstrated DIDS- and HCO3- -sensitive chloride and sulfate 
transport activity.  Furthermore, we demonstrated that the C-terminus of SLC26A6 binds to the first 
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and second PDZ domains of the E3KARP and NHERF proteins in vitro.  Truncation of the last 
three amino acids (TRL) of SLC26A6 abrogated the interaction, but did not affect transport 
function. These results demonstrate that SLC26A6 and its two splice variants can function as anion 
transporters linked to PDZ-interaction pathways. Our results support the general concept of 
microdomain organization for ion transport, and suggest a mechanism for CFTR-mediated 
SLC26A6 upregulation in pancreatic duct cells. 
 
In addition, three novel members, named SLC26A7, SLC26A8 and SLC26A9, were identified on 
chromosomes 8, 6 and 1, respectively.  The SLC26A7-A9 genes show tissue-specific expression in 
kidney, testis and lung, respectively.  Localisation by immunohistochemistry and/or in situ 
hybridization localized SLC26A7 to distal segments of nefrons, SLC26A8 to developing 
spermatocytes, and SLC26A9 to the lumenal side of the bronchiolar and alveolar epithelium of 
lung. Expression of SLC26A7-A9 proteins in Xenopus oocytes demonstrated chloride, sulfate and 
oxalate transport activity, suggesting that they encode functional anion exchangers.  The novel 
genes are likely to participate in important physiological functions involving anion transport in 
different organs and might associate with disorders. 
 
In this study, we have also compared the expression of three major mediators of the intestinal salt 
transport, SLC26A3 (Cl-/HCO3--exchanger), SLC9A3 (Na+/H+-exchanger) and CFTR (Cl--channel), 
between healthy and inflamed colonic mucosa to understand the pathophysiology of diarrhoea in 
inflammatory bowel disease. All three transporters do likely play in concert with each other, and 
their functional defects have been associated with diarrhoeal diseases. The activity of inflammation 
was determined by histological evaluation of the peroperative colonic samples graded in three 
subgroups (mild, moderate and severe), and the expression levels were measured by real-time 
quantitative RT-PCR, immunohistochemistry and immunoblotting.  Our results revealed the 
upregulation of CFTR expression but not SLC26A3 and SLC9A3 in ulcerative colitis, suggesting 
that the inhibition of CFTR might contribute to the therapy of diarrhoea in UC in the future. 
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1. INTRODUCTION 
A relatively constant cellular homeostasis is essential for body functions.  The cytoplasmic pH must 
be maintained within a narrow range in cells, while generating and responding to metabolic acid 
and base loads, and while maintaining acidic or alkaline environments within distinct subcellular 
compartments. To maintain the cell polarity and other functions, different concentrations of 
electrolytes in intra- and extracellular spaces must be tightly controlled by specific ion transport 
systems. Inorganic anions such as Cl-, HCO3- and SO42-, comprise an important group of 
electrolytes in body fluids.  Chloride is the most abundant anion in plasma, and it has many 
physiological roles in maintaining the cell polarity, cell volume, water absorption, and in 
transporting other ions such as sodium, bicarbonate and protons. Bicarbonate along with CO2 
comprises the major pH buffer of biological fluids, and it enhances the solubility of proteins and 
ions in biological fluids. Sulfate is an important constituent of macromolecules such as mucins and 
proteoglycans, and the regulation of the sulfate transport is required for proper cell growth and 
development of the organism.  
 
Hydrophilic, water-soluble anions cannot pass freely through membranes and need specific 
transport systems. Biochemical and biophysical studies on the red blood cell membrane proteins 
have paved the way for the identification of the mammalian anion transport systems (Kopito and 
Lodish 1985).  The most abundant protein of the red cells, Band 3 (AE1, SLC4A1), was the first 
identified anion exchanger, exhibiting a Na+-independent Cl-/HCO3- exchange activity. 
Subsequently, several additional SLC4A1-related genes have been cloned (Kopito 1990). More 
recently, the second structurally different anion exchanger family, SLC26, has been established 
mainly by positional cloning of disease genes (Kere et al. 1999).  
 
Anion exchangers have fundamental roles in many physiological processes such as maintenance of 
cell volume and intracellular pH.  Intracellular pH is regulated through coordinated action of several 
acid-base transporters (Fig. 1), including Na+/H+ exchangers (NHEs), Na+/HCO3- cotrasporters 
(NBCs), Na+-dependent Cl-/HCO3- exchangers (NCBEs), and Na+-independent Cl-/HCO3- anion 
exchangers (AEs) (Puceat et al. 1995; Soleimani and Burnham 2001).  Intracellular pH is a major 
regulator of diverse cellular processes including metabolic pathways, Ca2+ homeostasis, cell 
contractility, cell excitability, gene expression and cell death (Fabiato and Fabiato 1978; Fry and 
Poole-Wilson 1981; Busa and Nuccitelli 1984; Orchard and Kentish 1990; Isfort et al. 1993; 
Kusuoka et al. 1993; Gottlieb et al. 1996; McConkey and Orrenius 1996). Disruption of anion 
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metabolism leads to acid/base disturbances as well as other electrolyte abnormalities that may 
predispose to different pathophysiological conditions.    
 
Importantly, defects in the human anion transport systems have been associated with a wide range 
of distinct genetic diseases including spherocytic anemia, distal renal tubular acidosis, skeletal 
dysplasias, chloride diarrhoea, and congenital hearing loss with variably penetrant goiter 
(Hästbacka et al. 1994; Höglund et al. 1996; Everett et al. 1997; Alper 2002). Anion transport is 
also impaired in other pathophysiological states such as intestinal inflammations. By exploring the 
pathogenesis of these abnormalities much can be learned about the anion transport physiology in 
different parts of the body.   
 
An alternative route for expanding our understanding of the transport physiology can benefit from 
the tremendous advances that have been made in human genetics in recent years.  The fruits of the 
genome projects are facilitating the exploration of gene families and the identification of genes 
underlying different pathological conditions. An ever growing number of genomic sequences from 
different species is rapidly accumulating in databases allowing feasible identification, mapping and 
cloning of new genes. As a result, while new transport systems will emerge, many already 
functionally recognized transporters are also likely to get their molecular identity.  
 
As an example of the fruits of genome projects, the current study describes the expansion of the 
SLC26 family using a genome-driven approach. Seven new putative anion exchangers were 
identified in human. They are likely to possess important physiological functions or disease 
associations, providing new insights to anion transport physiology in different parts of the body.   
           
Figure 1. A schematic representation of acid-base transporters (adapted from Soleimani and 
Burnham 2001).  
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2. REVIEW OF THE LITERATURE 
 
2.1. The AE anion exchangers belongs to the SLC4 bicarbonate superfamily 
A classical family of at least three structurally and functionally related anion exchanger (AE) genes, 
AE1-AE3, has been identified from different species (Alper 1994). These anion exchangers 
constitute a diverse family of transporters, which contribute to the maintenance of transmembrane 
anion gradients, cell volume, and acid-base homeostasis.   
 
Table 1. Nomenclature of the SLC4 gene family. SLC4A6 has been withdrawn because of 
redundancy with SLC4A7 and SLC4A8. 
  Symbol Alternative name Chromosomal 
location 
OMIM Number GenBank 
Accession 
SLC4A1 AE1 17q12-q21 109270 XM008364 
SLC4A2 AE2 7q35-q36 109280 XM032121 
SLC4A3 AE3 2q36 106195 XM002605 
SLC4A4 NBC1 4q21 603351 AF007216 
SLC4A5 NBC4 2p13 - AF207661 
SLC4A7 NBC2 3p22 603353 AB012130 
SLC4A8 NBC3 Chr 12 605024 AF069512 
SLC4A9 AE4 Chr 5 - AF332961  
SLC4A10 NBCE 2q23-q24 605556 AB033759 
 
 
The AE family comprises a subfamily within the larger SLC4 bicarbonate transporter superfamily 
(Fig. 2) that includes also several Na+/HCO3- cotransporters (NBC) and two NBC-related genes, 
AE4 (NBC5, SLC4A9) and NDAE1 (Na-driven Cl-/base exchanger 1) (Soleimani and Burnham 
2001). Of interest, AE4 elicits Na+-independent Cl-/HCO3- activities, but shows higher structural 
homology to the members of the NBC family, being a structure intermediate between the NBCs and 
SLC4 proteins (Tsuganezawa et al. 2001). AE4 has been detected only in the apical membranes of 
HCO3--secreting β-intercalated cells in kidney. Since the HUGO Nomenclature Committee has 
recently revised the nomenclature of the gene family, the new SLC4A1-A3 symbols (AE1-AE3, 
respectively) will be used throughout this review (Table 1).  
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Figure 2. The evolutionary relationships among the mammalian SLC4 family of bicarbonate and 
anion transporters.  
 
2.1.1. Characteristics of SLC4A1-A3  
SLC4A1 is the most abundant protein of the red blood cell membrane, representing 10% of the 
surface area and ~25% of the total protein of the purified membrane (Steck et al. 1976). Because 
SLC4A1 is easily available, it has become one of the most studied membrane proteins. Although its 
functional and structural properties have been under extensive studies for many decades, the 
characterization of the primary structure had to await the isolation of the SLC4A1 cDNA clones 
(Kopito and Lodish 1985; Cox and Lazarides 1988; Tanner et al. 1988). Previous studies by direct 
peptide sequencing had yielded only a portion of the N-terminal domain and fragments from the 
membrane domain (Mawby and Findlay 1982; Brock et al. 1983; Kaul et al. 1983).  To date, the 
SLC4A1 gene has been cloned from several different species (Alper 1994). 
 
The human SLC4A1 gene maps to 17q21 (Showe et al. 1987) and encompasses 20 kb of DNA 
consisting of 20 exons. The cDNA sequence of 4906 nucleotides encodes a 911-amino-acid 
transmembrane glycoprotein (~100 kDa), with two domains having independent functions 
(Schofield et al. 1994). The amino-terminal 40-kDa of the SLC4A1 protein is located in cytoplasm 
and interacts with different cytoskeletal proteins, while the 55-kDa C-terminal membrane domain 
carries out the exchange of anions (Low 1986; Tanner 1997). SLC4A1 is glycosylated with a single 
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N-glycan chain at Asn642, which is not needed for the transport function (Jay 1986; Casey et al. 
1992).   
 
SLC4A1    1 -------------------------------------------------------------------------------- 
SLC4A2    1 MSSAPRRPAKGADSFCTPEPESLGPGTPGFPEQEEDELHRTLGVERFEEILQEAGSRGGEEPGRSYGEEDFEYHRQSSHH 
SLC4A3    1 MANGVIPPPGGASPLPQVRVPLEEPPLSPDVEEEDDDLGKTLAVSRFGDLISKPPAWDPEKPSRSYSERDFEFHRHTSHH 
 
SLC4A1    1 ---------------------------------------------MEEL-------QDDYEDMMEEN------------- 
SLC4A2   81 IHHPLSTHLPPDARRRKTPQGPGRKPRRR-----PGASPTGETPTIEEG-------EEDEDEASEAEGARALTQPSPVST 
SLC4A3   81 THHPLSARLPPPHKLRRLPPTSARHTRRKRKKEKTSAPPSEGTPPIQEEGGAGVDEEEEEEEEEEGESEAEPVEPPHSGT 
 
SLC4A1   16 -------LEQEEYED--------PDIPE------------------SQMEEPAAH------------------------- 
SLC4A2  149 PSSVQFFLQEDDSADRKAE-RTSPSSPAPLPHQEATPRASKGAQAGTQVEEAEAEAVAVASGTAGGDDGGASGRPLPKAQ 
SLC4A3  161 PQKAKFSIGSDEDDSPGLPGRAAVTKPLPSVGPHTDKSPQHSSRPCSELRDGDGTTDLALSSPRLLCCLPSSPSPRARAS 
 
SLC4A1   38 ---------------------------------------------DTEATATDYHTTSH--------------------- 
SLC4A2  228 ----------PGHRSYNLQERRRIGSMTGAEQALLPRVPTDEIEAQTLATADLDLMKSHRFEDVPGVRRHLVRKNAKGST 
SLC4A3  241 RLAGEKSRPWSPSASYDLRERLCPGSALGNPGGPEQQVPTDEAEAQMLGSADLDDMKSHRLEDNPGVRRHLVKKPSRTQG 
 
SLC4A1   52 --------PG--------------THKVYVELQELVMDEKNQELRWMEAARWVQLEENLGEN-GAWGRPHLSHLTFWSLL 
SLC4A2  298 QSGREGREPGPTPRARPRA--PHKPHEVFVELNELLLD-KNQEPQWRETARWIKFEEDVEEETERWGKPHVASLSFRSLL 
SLC4A3  321 GRGSPSGLAPILRRKKKKKKLDRRPHEVFVELNELMLD-RSQEPHWRETARWIKFEEDVEEETERWGKPHVASLSFRSLL 
 
SLC4A1  109 ELRRVFTKGTVLLDLQETSLAGVANQLLDRFIFEDQIRPQDREELLRALLLKHSH---------------AGELEALGGV 
SLC4A2  375 ELRRTLAHGAVLLDLDQQTLPGVAHQVVEQMVISDQIKAEDRANVLRALLLKHSHPSDEKDF-SFPRNISAGSLGSLLGH 
SLC4A3  400 ELRRTIAHGAALLDLEQTTLPGIAHLVVETMIVSDQIRPEDRASVLRTLLLKHSHPNDDKDSGFFPRNPSSSSMNSVLGN 
 
SLC4A1  174 KPAVLTRSG-DPSQPLLP--QHSSLETQLFCEQ-------GDGGTEGHSPSGILEKIPPDSEATLVLVGRADFLEQPVLG 
SLC4A2  454 HHGQGAESDPHVTEPLMGGVPETRLEVERERELPPPAPPAGITRSKSKHELKLLEKIPENAEATVVLVGCVEFLSRPTMA 
SLC4A3  480 HHPTPSHGPDGAVPTMADDLGEPAPLWPHDPDAKEKPLHMPGGDGHRGKSLKLLEKIPEDAEATVVLVGCVPFLEQPAAA 
 
SLC4A1  244 FVRLQEAAELEAV-ELPVPIRFLFVLLGPEAPHIDYTQLGRAAATLMSERVFRIDAYMAQSRGELLHSLEGFLDCSLVLP 
SLC4A2  534 FVRLREAVELDAVLEVPVPVRFLFLLLGPSSANMDYHEIGRSISTLMSDKQFHEAAYLADEREDLLTAINAFLDCSVVLP 
SLC4A3  560 FVRLNEAVLLESVLEVPVPVRFLFVMLGPSHTSTDYHELGRSIATLMSDKLFHEAAYQADDRQDLLSAISEFLDGSIVIP 
 
SLC4A1  323 PTDAPSEQALLSLVPVQRELLRRRYQSSPAKP-----------DSSFYKGLDLN-GGP-DDPLQQTGQLFGGLVRDIRRR 
SLC4A2  614 PSEVQGEELLRSVAHFQRQMLKKREEQGRLLPTGAGLEPKSAQDKALLQMVEAA-GAAEDDPLRRTGRPFGGLIRDVRRR 
SLC4A3  640 PSEVEGRDLLRSVAAFQRELLRKRREREQTKVEMTTRGGYTAPGKELSLELGGSEATPEDDPLLRTGSVFGGLVRDVRRR 
 
SLC4A1  390 YPYYLSDITDAFSPQVLAAVIFIYFAALSPAITFGGLLGEKTRNQMGVSELLISTAVQGILFALLGAQPLLVVGFSGPLL 
SLC4A2  693 YPHYLSDFRDALDPQCLAAVIFIYFAALSPAITFGGLLGEKTQDLIGVSELIMSTALQGVVFCLLGAQPLLVIGFSGPLL 
SLC4A3  720 YPHYPSDLRDALHSQCVAAVLFIYFAALSPAITFGGLLGEKTEGLMGVSELIVSTAVLGVLFSLLGAQPLLVVGFSGPLL 
 
SLC4A1  470 VFEEAFFSFCETNGLEYIVGRVWIGFWLILLVVLVVAFEGSFLVRFISRYTQEIFSFLISLIFIYETFSKLIKIFQDHPL 
SLC4A2  773 VFEEAFFSFCSSNHLEYLVGRVWIGFWLVFLALLMVALEGSFLVRFVSRFTQEIFAFLISLIFIYETFYKLVKIFQEHPL 
SLC4A3  800 VFEEAFFKFCRAQDLEYLTGRVWVGLWLVVFVLALVAAEGSFLVRYISPFTQEIFAFLISLIFIYETFYKLYKVFTEHPL 
 
SLC4A1  550 QKTYNYNVLMVP----------------------------KPQGPLPNTALLSLVLMAGTFFFAMMLRKFKNSSYFPGKL 
SLC4A2  853 HGCSASNSSEVDGGENMTWAGARPTLGPGNRSLAGQSGQGKPRG-QPNTALLSLVLMAGTFFIAFFLRKFKNSRFFPGRI 
SLC4A3  880 LPFYPPEGALEG--------SLDAGLEPNGSALPPTEGPPSPRN-QPNTALLSLILMLGTFFIAFFLRKFRNSRFLGGKA 
 
SLC4A1  602 RRVIGDFGVPISILIMVLVDFFIQDTYTQKLSVPDGFKVSNSSARGWVIHPLGLRSEFPIWMMFASALPALLVFILIFLE 
SLC4A2  932 RRVIGDFGVPIAILIMVLVDYSIEDTYTQKLSVPSGFSVTAPEKRGWVINPLGEKSPFPVWMMVASLLPAILVFILIFME 
SLC4A3  951 RRIIGDFGIPISILVMVLVDYSITDTYTQKLTVPTGLSVTSPDKRSWFIPPLGSARPFPPWMMVAAAVPALLVLILIFME 
 
SLC4A1  682 SQITTLIVSKPERKMVKGSGFHLDLLLVVGMGGVAALFGMPWLSATTVRSVTHANALTVMGKASTPGAAAQIQEVKEQRI 
SLC4A2 1012 TQITTLIISKKERMLQKGSGFHLDLLLIVAMGGICALFGLPWLAAATVRSVTHANALTVMSKAVAPGDKPKIQEVKEQRV 
SLC4A3 1031 TQITALIVSQKARRLLKGSGFHLDLLLIGSLGGLCGLFGLPWLTAATVRSVTHVNALTVMRTAIAPGDKPQIQEVREQRV 
 
SLC4A1  762 SGLLVAVLVGLSILMEPILSRIPLAVLFGIFLYMGVTSLSGIQLFDRILLLFKPPKYHPDVPYVKRVKTWRMHLFTGIQI 
SLC4A2 1092 TGLLVALLVGLSIVIGDLLRQIPLAVLFGIFLYMGVTSLNGIQFYERLHLLLMPPKHHPDVTYVKKVRTLRMHLFTALQL 
SLC4A3 1111 TGVLIASLVGLSIVMGAVLRRIPLAVLFGIFLYMGVTSLSGIQLSQRLLLILMPAKHHPEQPYVTKVKTWRMHLFTCIQL 
 
SLC4A1  842 ICLAVLWVVKSTPASLALPFVLILTVPLRRVLLPLIFRNVELQCLDADDAKATFDEEEGRDEYDEVAMPV 
SLC4A2 1172 LCLALLWAVMSTAASLAFPFILILTVPLRMVVLTRIFTDREMKCLDANEAEPVFDEREGVDEYNEMPMPV 
SLC4A3 1191 GCIALLWVVKSTAASLAFPFLLLLTVPLRHCLLPRLFQDRELQALDSEDAEPNFDE-DGQDEYNELHMPV 
 
Figure 3. Multiple alignment of the anion exchangers of the SLC4 family. The identical and 
conserved residues are shown in black and gray, respectively. 
 
Soon after the identification of SLC4A1, two related genes, SLC4A2 and A3, were cloned from 
numerous species by low stringency hybridizations (Demuth et al. 1986; Alper et al. 1988; Kopito 
et al. 1989; Kudrycki et al. 1990; Lindsey et al. 1990; Gehrig et al. 1992).  The SLC4A2 gene maps 
to 7q35-q36 (Palumbo et al. 1986) and extends over 17 kb of genomic sequence. The cDNA 
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consists of 23 exons and 22 introns.  Nine exons are of the same size as the corresponding exons of 
SLC4A1, and their overall genomic structures resemble each other (Medina et al. 1997).  The 
SLC4A2 gene encodes a 1241 amino acid transmembrane protein, which differs mostly in its N-
terminal region from that of SLC4A1 (Fig. 3).   
 
The SLC4A3 gene was found in excitable tissues (Kopito et al. 1989; Su et al. 1994).  The gene 
maps to 2q36, and encodes a 1232 amino acid transmembrane protein. SLC4A2 and A3 show 
stronger homology with each other than with SLC4A1. Furthermore, the N-terminus of SLC4A1 is 
~300 amino acids shorter as compared to SLC4A2 and A3 (Fig. 3).  Generally, the C-terminal 
membrane domains share the highest degree of amino acid identity (~67%) among the family 
members (Alper 1991).   
 
The structure of the anion exchangers has been under extensive study for a long time. Most studies 
have focused on the SLC4A1 protein, which would serve as a prototype for the other members.  
Hydropathy analysis of the SLC4A1 amino acid sequence combined with experimental evidence 
derived from covalent labeling studies using impermeant reagents, proteolysis and antibody epitope 
mapping predicts topology models containing 12-14 membrane spans (Fig. 4) (Tanner 1993; Popov 
et al. 1997; Fujinaga et al. 1999; Popov et al. 1999).   
 
At cellular level, the structure is still more complex, since SLC4A1 has been observed to form self-
assembling oligomeric structures. The basic functional unit is homodimer (Wang et al. 1993).  A 
three-dimensional map of the dimeric membrane domain has been determined using electron 
microscopy of two-dimensional crystals (Wang et al. 1994).  The dimeric membrane domain shows 
a canyon-like structure, consisting of a basal domain and two large protrusions.  However, 
structural details are limited to low-resolution (20Å), and further studies are required to understand 
their functional relevance.   
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Figure 4. Predicted topology of the SLC4A1 protein (modified from Popov et al. 1998). The first 
358 N-terminal amino acid residues have not been included in the figure. 
 
2.1.2. Tissue distributions of SLC4A1-A3 
Tissue distribution among the SLC4 family members varies considerably and reflects the tissue-
specific functions of the proteins. Furthermore, the use of tissue-specific alternate promoters has 
been reported to all members (Linn et al. 1992; Sahr et al. 1994; Medina et al. 2000). Although, 
SLC4A1 is mainly expressed in red blood cells, it has been found also in many other tissues such 
brain, testis, lung, liver and gastrointestinal tract. An amino-terminal variant of SLC4A1 has been 
found in the basolateral membrane of type A intercalated cells of the renal cortical and medullary 
collecting ducts.  This kidney-specific SLC4A1 lacks the first 65 residues of erythrocyte SLC4A1, 
which results from alternative promoter usage.  Furthermore, a novel SLC4A1 isoform, nSLC4A1, 
has recently been cloned from rat heart, and proposed to be the predominant anion exchanger in 
cardiac ventricular myocytes (Alper et al. 1987; Brosius et al. 1989; Kudrycki and Schull 1989; 
Kudrycki et al. 1990; Kay et al. 1991; Puceat et al. 1995; Richards et al. 1999).   
 
The SLC4A2 gene is transcribed in a wide variety of tissues and it has been present in almost all 
tissues examined so far.  SLC4A2 is expressed in both epithelial and nonepithelial cells, and it is 
located mainly to the basolateral membrane of the cells.  In human, the most abundant expression of 
SLC4A2 is seen in gastric parietal cells. Recently, the full-length isoform of SLC4A2 is localized to 
the Golgi, suggesting that it may play a role in the regulation of the anion exchange activity in 
intracellular membranes as well (Alper et al. 1988; Kudrycki et al. 1990; Lindsey et al. 1990; Alper 
1994; Jons et al. 1994; Negrini et al. 1995; Wang et al. 1996; Holappa et al. 1999; Alferai et al. 
 17
     
2001; Holappa et al. 2001).  Furthermore, five N-terminal SLC4A2 variants have been identified in 
mammals (Stuart-Tilley et al. 1998; Lecanda et al. 2000). 
 
SLC4A3 is found at highest level in excitable tissues such as brain, heart and retina (Kopito et al. 
1989; Linn et al. 1992; Kobayashi et al. 1994), but also in kidney, smooth muscle cells and 
throughout the gastrointestinal tract (Kudrycki et al. 1990; Brosius et al. 1997).  Two different 
isoforms, bSLC4A3 and cA3, have been identified in heart, retina and smooth muscle cells (Linn et 
al. 1992; Kobayashi et al. 1994; Linn et al. 1995). cSLC4A3 contains 1034 amino acids, including 
the unique 73-amino-acid domain at the N-terminus (Yannoukakos et al. 1994). cSLC4A3 is most 
abundant variant expressed in heart, whereas in the retina bSLC4A3 and A3c are expressed at 
similar levels, but in different retinal cell layers. In addition, bSLC4A3 has been localized to both 
apical and basolateral membranes, whereas SLC4A3c localizes mainly to apical membranes (Alper 
et al. 1995).   
 
2.1.3. Diverse biological functions of SLC4A1-A3 
Besides regulating intracellular pH via the Cl-/HCO3- exchange, the members of the SLC4 family 
exert various cellular functions including anchorage of the cytoskeleton to the membrane, 
regulation of metabolism, and generation of a senescence antigen. The first assignment of anion 
transport function for SLC4A1 was based on studies searching potent anion exchange inhibitors 
(Cabantchik 1990). Most importantly, SLC4A1 and carbonic anhydrase (CA) catalyze 
interconnected processes involved in blood gas exchange (Sly and Hu 1995). In the peripheral 
tissues, CO2 diffuses into the erythrocytes and is hydrated by CA. The resulting bicarbonate is 
transported into the blood plasma by SLC4A1.  In the lungs, the process is reversed: bicarbonate 
enters the red cell via SLC4A1 and is dehydrated by CA, and the resulting CO2 diffuses out of the 
red cells. Each SLC4A1 protein has been proposed to transport ~100 000 pairs of monovalent 
anions per second, which is the largest ion-specific flux known for any single cell in the body 
(Weith et al. 1982). 
 
Anion specificity of SLC4A1 includes also a wide range of oxyanions such as sulfate, selenate, 
selenite and phosphate (Galanter et al. 1993; Sekler et al. 1995; Dale et al. 1996). Transport activity 
can be inhibited by stilbene disulfonates, DIDS and SITS, which are known anion exchanger 
specific inhibitors (Salhany 1998).  The transport function is related to the C-terminal membrane 
domain, which can be removed from the N-terminus without affecting the anion transport function 
(Grinstein et al. 1978). Interestingly, distinct functional features have been found in different 
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species: trout anion exchanger (tslc4a1), but not the mouse slc4a1, elicits, in addition to anion 
exchange activity, both anion conductance and transport of uncharged organic solutes such as 
taurine, urea and sorbitol (Fievet et al. 1998).  Recently, the short acidic cytoplasmic domain in the 
ultimate C-terminus of SLC4A1 has been observed to bind to carbonic anhydrase II to promote 
bicarbonate transport across cell membranes (Vince and Reithmeier 2000). 
 
In addition to ionic homeostasis, SLC4A1 provides the mechanical stability in erythrocytes, serving 
as a critical attachment site for different cytoskeletal components (Low 1986).  A structural 
component of erythrocytes, spectrin, is able to bind to N-terminus of SLC4A1 via ankyrin and Band 
4.1, making it essential for maintaining cell shape and mechanical strength (Bennett 1989; Davis 
and Bennett 1990).   The highly acidic N-terminus of SLC4A1 participates also in glucose and 
oxygen metabolisms, since the N-terminus provides an association site for glycolytic enzymes, 
glyceraldehyde-3-phosphodehydrogenase (G3PDH), aldolase, phosphofructokinase as well as 
catalase, hemoglobin, hemichromes, band 4.1 and band 4.2 (Low 1986; Bennett 1989; Matayoshi 
and Jovin 1991).   There is also evidence for glycophorin A (GPA) and SLC4A1 interaction during 
their biosynthesis and processing.  In red blood cells lacking GPA, the average length of N-glycan 
chain attached to SLC4A1 is increased and the anion transport activity of SLC4A1 is decreased, 
suggesting that SLC4A1 is dependent on GPA for efficient translocation to the membrane and for 
final processing in order to adopt active conformation (Gahmberg et al. 1976; Groves and Tanner 
1992).  These results have been confirmed recently in SLC4A1 knockout mice, which indicate that 
GPA is not expressed in the red cell membranes in the absence of SLC4A1 (Hassoun et al. 1998). 
The kidney-specific isoform of SLC4A1 binds to the kanadaptin protein and has been suggested to 
regulate blood pH (Chen et al. 1998).  The SLC4A1 protein has been suggested to act as a 
senescence antigen for aged and damaged red cells (Kannan et al. 1988) 
 
Cl-/HCO3- exchange mediated by SLC4A1 displays a broad pH versus activity profile, consistent 
with its role in facilitating the CO2 metabolism. In contrast, SLC4A2 has been proposed to function 
as a highly pH-sensitive anion exchanger in different transport systems.  It mediates Cl- influx in 
Xenopus oocytes (Alper et al. 1989), and induces a DIDS-sensitive Cl-/HCO3- exchange in various 
mammalian cell lines (Lindsey et al. 1990; Lee et al. 1991; Sekler et al. 1995).  The activity of 
SLC4A2 can be enhanced at alkaline pH, consistently with the possible role of SLC4A2 in the 
control of intracellular pH (Lee et al. 1991; Humphreys et al. 1994; Humphreys et al. 1995; 
Humphreys et al. 1997). Furthermore, SLC4A2 exhibits several modes of regulation not displayed 
by SLC4A1: it can be inhibited by protons, activated by hypertonicity and ammonium ion, and 
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SLC4A2 can mediate regulatory volume increase in Xenopus oocytes, while SLC4A1 lacks these 
properties (Humphreys et al. 1994; Jiang et al. 1994; Humphreys et al. 1995; Humphreys et al. 
1997).    
 
Two different models have been proposed for the pH sensitive modulation of the SLC4A2 activity. 
In human embryonic kidney (HEK) 293 cell line, the possible “pH sensor” of SLC4A2 has been 
mapped to a cluster of four histidine residues located within the extreme N-terminus of SLC4A2 
and A3, but absent from SLC4A1 (Sekler et al. 1996). In contrast, the Xenopus oocyte experiments 
suggested that the pH sensor of SLC4A2 is intrinsic to the membrane domain and is subject to 
modulation by a modifier site located within the N-terminal cytoplasmic domain (Zhang et al. 
1996). These results were further defined within the NH2-terminal domain, which demonstrated 
distinct structural requirements for SLC4A2 regulation by intracellular and extracellular protons 
(Stewart et al. 2001). In spite of the differences of the pH sensor site of SLC4A2, both models 
suggested that the pH-dependent modulation of the transport activity probably requires an 
interaction between the cytoplasmic N-terminus and the catalytically active C-terminal membrane 
domain (Sekler et al. 1996; Zhang et al. 1996).  
 
The SLC4A3 protein functions also as a DIDS-sensitive, Na+-independent anion exchanger, 
regulating both the intracellular pH and Cl- gradients in excitable cells.  Expression of SLC4A3 in 
COS cells demonstrated cytoplasmic acidification and led to chloride- and bicarbonate-dependent 
changes in intracellular pH (Kopito et al. 1989; Sterling and Casey 1999).  The full-length SLC4A3, 
which is postulated to regulate the intracellular pH in glial cells, contains the pH sensor domain 
similar to SLC4A2 (Sekler et al. 1996).  However, the SLC4A3c isoform that predominates in the 
heart lacks the N-terminal 270 amino acids that encompasses the pH sensor, consistently with its 
proposed role as a regulator of the Cl- gradient rather than the pHi in these cells (Kudrycki et al. 
1990; Sekler et al. 1996).   
 
2.1.4. Anion exchangers of the SLC4 family in pathophysiological states 
The naturally occurring variants and mutations of SLC4A1 have been linked to different diseases 
such as Southeast Asian ovalocytosis, hereditary spherocytosis and distal renal tubular acidosis of 
both dominant and recessive forms (Bruce and Tanner 1999; Alper 2002).  Furthermore, abnormal 
expression of SLC4A1 and A2 mRNAs has been observed in primary biliary cirrhosis (PBC), 
suggesting that they may have a role in cholestasis, secretory failure, and immunodysfunction of 
PBC (Prieto et al. 1993; Medina et al. 1997).  An autosomal recessive neurological disease, 
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choreoachantocytosis, has been associated with the altered C-terminus of SLC4A1 (Kay et al. 1990; 
Kay et al. 1991). Abnormal SLC4A1 has been found also in brains from Alzheimer disease patients 
(Kay 1991). However, naturally occurring mutations for SLC4A2 and A3 have not been reported so 
far.    
 
Expression of SLC4A1 in red cell membranes is important to the organization of the membrane 
layer, and the defective protein may affect the morphology and stability of the red cell membrane.  
Two different phenotypes have been linked to structural abnormalities including Southeast Asian 
ovalocytosis (SAO) and hereditary spherocytosis.  SAO occurs mainly in Malesian populations, 
although it has also been found in some other countries (Bruce and Tanner 1999).  The SAO 
phenotype is asymptomatic, but it has been associated with protection against cerebral malaria in 
endemic areas (Genton et al. 1995).  SAO results from the deletion of amino acid 400-408 of 
SLC4A1 (Schofield et al. 1992), which alters the protein structure abolishing its transport function, 
binding to inhibitors and N-glycosylation (Sarabia et al. 1993; Chambers et al. 1999).  SAO red 
cells have been shown to be more rigid than normal red cells, suggesting that the deletion abrogates 
the proper interaction of SLC4A1 with the cytoskeleton (Mohandas et al. 1992). The altered 
SLC4A1 in SAO forms heterodimers and affects the normal population of SLC4A1 in red cells 
(Jennings and Gosselink 1995), reducing the anion transport activity of red cells about 60% 
compared to that in normal cells (Schofield et al. 1992). All the known individuals with SAO have 
been heterozygotes for SLC4A1, suggesting that the homozygous condition is lethal (Liu et al. 
1994). 
 
Most of the SLC4A1 mutations have been linked to autosomal dominant hereditary spherocytosis 
(Hassoun and Palek 1996; Bruce and Tanner 1999).  It is characterized by spherocytic red cells with 
increased osmotic and mechanical fragility and results in haemolytic anemia. The spherocytic shape 
of red cells results from the loss of surface membrane area relative to intracellular volume. HS 
missense mutations are distributed throughout the SLC4A1 cytoplasmic and transmembrane 
domains. Certain mutations associated with HS have been shown to affect the protein 4.2 and 
ankyrin binding sites on SLC4A1 disrupting the cytoskeleton (Rybicki et al. 1993; Inoue et al. 
1998). However, most of the mutations reduce the amount of SLC4A1 in the red cell membrane due 
to an unstable mRNA or degradation and mistargeting of the protein.  Subsequently, the decreased 
expression of SLC4A1 in red cells leads to a proportional reduction in protein 4.2 expression 
destabilizing the membrane lipid bilayer and resulting in HS (Lux and Palek 1996).   
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The majority of the SLC4A1 mutations reported to date cause only erythroid abnormalities without 
renal phenotype.  However, some of the SLC4 mutations, which are restricted to transmembrane 
domain have been associated with both dominant and recessive distal renal tubular acidosis (dRTA) 
(Bruce et al. 1997; Jarolim et al. 1998; Karet et al. 1998; Tanphaichitr et al. 1998). Interestingly, 
HS- and dRTA-associated mutations segregate almost completely, and only in two cases have 
homozygous recessive SLC4A1 mutations associated with anemia and dRTA (Lima et al. 1997; 
Rysava et al. 1997; Ribeiro et al. 2000).   
 
The spectrum of clinical severity in dRTA is wide and correlation of genotype and phenotype can 
vary within individual families (Weber et al. 2000). The main symptoms of dRTA patients are 
characterized by reduced ability to acidify urine leading to variable hypochloremic metabolic 
acidosis, which is usually accompanied by nephrocalcinosis, kidney stones and metabolic bone 
disease.  However, alkali replacement can reverse most of the biochemical abnormalities.  Some 
patients with dominant dRTA remain asymptomatic until adolescence or adulthood, whereas those 
with the recessive disease may be severely affected in infancy, with impaired growth and early 
nephrocalcinosis causing eventual renal insufficiency.  Many patients with recessive dRTA have 
also sensorineural deafness (Battle et al. 2001). 
 
Functional studies on the dominant dRTA-associated SLC4A1 mutations have exhibited only 
moderate or mild decrements in the protein function, and the abundance of SLC4A1 in red cell 
membranes has been normal (Jarolim et al. 1998).  The first recessive dRTA mutation, G701D, 
produced a conditional trafficking phenotype.  Its folding and trafficking was dependent on the 
presence of glycophorin A, and because intercalated cells in kidney lacks this protein, SLC4A1 
G701D could not accumulate at the cell surface.  Consistently, SLC4A1 content and function were 
normal in patient red cell, which express GPA (Alper 2002).  In addition, some recessive and 
compound heterozygous mutations have been shown to exhibit reduced transport activity (Bruce et 
al. 2000). However, additional functional studies will be required to understand SLC4A1-associated 
dominant and recessive dRTA in the absence of erythroid disease. 
 
The pathophysiology of the SLC4A1-related diseases has been assessed also in two mouse models 
by selectively inactivating the erythroid but not kidney SLC4A1 (Peters et al. 1996; Southgate et al. 
1996).  The SLC4A1 null mice showed retarded growth, spherocytic red blood cell morphology, 
and severe hemolytic anemia.  The majority of homozygous mice died within 2 weeks after birth. 
The expression of ankyrin-1 was decreased ~50% in SLC4A1-/- membranes and SLC4A1-binding 
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proteins 4.2 and glycophorin A were missing (Hassoun et al. 1998). However, the SLC4-/- 
erythrocytes assembled a normal membrane skeleton, thereby challenging the previous hypothesis 
that the presence of SLC4A1 is essential for the stable biogenesis of membrane skeleton (Peters et 
al. 1996; Southgate et al. 1996).  
 
In another study, the gene targeting produced a null mutation that disrupted both the red blood cell 
and kidney AE1 isoforms.  This resulted in a hypercoagulable state due to disruption of the 
phospholipid asymmetry of the red blood cell membrane.  Moreover, a widespread thrombosis in 
vivo was observed, with only 5-10% of mice surviving the neonatal period (Peters et al. 1996; 
Hassoun et al. 1998).  Similar observations have also been found from cattle red blood cells with a 
naturally occurring homozygous nonsense mutation of the SLC4A1 gene (Inaba et al. 1996).   
 
2.2. The SLC26 gene family defines a new group of anion exchangers 
As the biochemical and biophysical studies on the red blood cell membrane paved the way for the 
exploration of the SLC4 gene family of anion exchangers, the identification of the second anion 
exchanger family was mainly based on the positional cloning of the genes for different genetic 
diseases. Strikingly, clinically distinct diseases, diastrophic dysplasia, congenital chloride diarrhoea 
and Pendred syndrome, bearing no obvious resemblance to one another turned out to be caused by 
defects in genes, which belong to the same gene family. The clearly distinguishable group of the 
previously so-called sulfate transporters was then recently redefined functionally as the second 
anion exchanger gene family, SLC26 (Kere et al. 1999).   
 
2.2.1. Rat slc26a1 functions as a sulfate/anion exchanger in hepatocytes 
The first member of the SLC26 family, named sulfate anion transporter-1, was isolated from a rat 
liver cDNA library by expression cloning, as a result from the search for novel mammalian sulfate 
transporter systems (Bissig et al. 1994).  The rat slc26a1 cDNA of 3.7 kb encodes a protein of 703 
amino acids. The protein sequence contains three putative N-glycosylation sites, several 
phosphorylation sites and 15 putative N-myristylation sites. Hydrophobicity analysis suggests 12 
putative transmembrane segments with intracellular N- and C-termini. Northern analysis indicated 
that SLC26A1 is most abundant in the liver and kidney, and with weaker signals in the skeletal 
muscle and brain.  More detailed analysis using immunohistochemistry localized slc26a1 to the 
basolateral membrane of the proximal tubules in kidney (Karniski et al. 1998).  In rat brain, slc26a1 
was located in hippocampus and cerebellum, suggesting that it may play a role in sulfate transport 
in neuronal or glial cells (Lee et al. 1999).    
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Functional expression of rat slc26a1 has established its function as a Na+-independent sulfate 
transporter that is strongly inhibited by DIDS and oxalate, but not by succinate or cholate (Bissig et 
al. 1994).  These properties correlate with the rat liver mRNA induced sulfate transport in oocytes, 
and the functional activities of the sulfate/bicarbonate exchanger in liver canalicular membrane 
vesicles (Meier et al. 1987; Palacin et al. 1990). Similar results were observed also with the rat 
kidney and brain injected mRNAs, confirming that slc26a1 transports sulfate, oxalate and 
bicarbonate (Markovich et al. 1994; Lee et al. 1999).   
 
2.2.2. Defective sulfate transport of SLC26A2 causes skeletal dysplasias 
The second member of the SLC26 family was found in a search for diastrophic dysplasia (DTD) 
gene. DTD (OMIM 222600) is an autosomal recessive chondrodysplasia characterized with short-
limbed dwarfism, spinal deformation, and generalized dysplasia of joints (Walker et al. 1972). A 
linkage disequilibrium approach mapped the diseases to 5q31-q34, which included a candidate gene 
that was not expressed in fibroblasts derived from the DTD patients (Hästbacka et al. 1990). The 
novel clone shared a significant homology with the recently identified rat slc26a1, making it very 
interesting, because one of the histological abnormalities of DTD patients is a deficient staining of 
sulfated proteoglycans in cartilage (Scheck et al. 1978). Subsequently, several point mutations were 
found in the gene, confirming that it was responsible for DTD (Hästbacka et al. 1994).  The gene 
became known as diastrophic dysplasia sulfate transporter, DTDST, which is currently designated 
as SLC26A2. 
 
The human SLC26A2 is comprised of four exons and three introns spanning over 40 kb (Clines and 
Lowett 1996). The gene contains an open reading frame of 739 amino acids with a molecular 
weight of 82 kDa. The hydropathy analysis of the sequence predicts a membrane protein with 12 
transmembrane segments with highly charged cytoplasmic domains at both N- and C-termini. Two 
potential N-glycosylation sites can be found from the extracellular loop. The protein sequence 
showed strong sequence similarity to rat slc26a1, suggesting a putative function for SLC26A2 
(Hästbacka et al. 1994).  The mouse slc26a2 gene (named st-ob for sulfate transporter in osteoblast) 
has been recently isolated from immature mouse fibroblastic cells (Kobayashi et al. 1998). 
 
SLC26A2 is widely expressed, although cartilage is the only tissue affected by its defective 
function (Hästbacka et al. 1994; Satoh et al. 1998). By in situ hybridization and 
immunohistochemistry, SLC26A2 expression localized to the secretory structures of different cell 
 24
     
types such as fetal hyaline cartilage, adult bronchial cartilage, eccrine sweat gland, bronchial 
glands, placental villi, exocrine pancreas and colon (Haila et al. 2000; Haila et al. 2001).  
Furthermore, SLC26A2 has been suggested to function as a Cl-/SO42- exchanger, because it can 
induce a DIDS-sensitive Na+- independent SO42- transport that can be inhibited by chloride, 
thiosulfate and oxalate (Satoh et al. 1998). These results are also consistent with the defective 
sulfate uptake of DTD patient fibroblasts and chondrocytes (Hästbacka et al. 1994; Rossi et al. 
1996).   
 
Four recessively inherited chondrodysplasias has been associated with over 30 mutations found in 
the SLC26A2 gene: diastrophic dysplasia (DTD), atelosteogenesis type 2 (AO2), achondrogenesis 
type 1B (ACG-1B) and recessive multiple epipyseal dysplasia (rMED) (Rossi and Superti-Furga 
2001). This skeletal dysplasia family ranges from a relatively benign condition to a severe 
derangement of skeletal development incompatible with life.  The mutations likely reduce the rate 
of sulfate flux from the pericellular space into cytoplasm, and result in undersulfation of 
proteoglycans as the consequence of intracellular sulfate pool depletion, leading to different disease 
phenotypes. Genotype-phenotype correlations indicate that the amount of residual activity of 
SLC26A2 strictly modulates the phenotype from lethal ACG1B to nonlethal DTD. Homozygosity 
or compound heterozygosity for stop codons or transmembrane domain substitutions mostly result 
in ACG-1B, while other structural or regulatory mutations usually result in a less severe phenotype.  
Although the nature of the mutations at SLC26A2 appears to explain much of the phenotypic 
difference among the three diseases, other factors may also play a role (Hästbacka et al. 1994; 
Hästbacka et al. 1996; Superti-Furga et al. 1996; Superti-Furga et al. 1996; Karniski 2001). 
 
DTD is a skeletal dysplasia associated with short stature, joint contractures, cleft palate, and 
characteristic clinical signs such as hitch-hiker thumb and cystic swelling of external ears (Horton et 
al. 1978; Horton 1996). Skeletal defects are clinically diagnosable early in fetal development 
(Kaitila et al. 1983). Patients are severely handicapped and need repeated corrective surgery, but 
their intelligence and sexual development are within the normal range. In infancy, respiratory and 
spinal abnormalities lead to increased mortality, but thereafter life span is not remarkably decreased 
(Walker et al. 1972).  
 
AO2 (OMIM 256050) is a more severe, neonatally lethal chondrodysplasia whose clinical and 
histological characteristics resemble those of the much less severe diastrophic dysplasia. Patients 
die of respiratory insufficiency shortly after birth because of the collapse of the airways and 
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pulmonary hypoplasia due to the small rib cage (Sillence et al. 1987). ACG-1B is lethal and 
characterized by extremely short limbs and characteristic radiographic appearance (Borochowitz et 
al. 1988). Affected individuals are usually born before term as stillborns or die immediately after 
birth.  The latest addition to the SLC26A2 skeltal dysplasia family is a condition with clubfoot and 
mild finger deformity but absence of palatal clefting, ear swelling, or thumb deviation, and mildly 
shortened or normal stature, which has been classified as recessively inherited multiple epiphyseal 
dysplasia, rMED (OMIM 226900) (Superti-Furga et al. 1999; Superti-Furga et al. 2000).  
 
2.2.3. SLC26A3 is an intestinal anion exchanger defective in chloride diarrhoea 
The second member of the human SLC26 family was found by positional cloning of the congenital 
chloride diarrhoea (CLD) gene (Kere et al. 1993; Höglund et al. 1996). Studies with Finnish CLD 
families mapped the disease to 7q31-q32 and identified a disease gene, DRA, mutated in CLD 
(Kere et al. 1993; Höglund et al. 1996). The CLD gene has been recently symbolized as SLC26A3. 
 
The SLC26A3 gene was originally isolated from a normal colon tissue cDNA library as a tumor 
suppressor candidate gene down-regulated early in tumorigenesis (Schweinfest et al. 1993). It 
comprises 39 kb of DNA and contains 21 exons (Haila et al. 1998). Its mRNA includes an open 
reading frame of 764 amino acids, encoding a 10-, 12- or 14-transmembrane glycoprotein (Fig. 5). 
The overall amino acid sequence homology is ~50% compared to SLC26A2. The deduced protein 
structure resembles a typical ion transporter molecule, being composed of multiple hydrophobic 
transmembrane domains with cytoplasmic N- and C-termini. The SLC26A3 protein may be 
variably N-glycosylated and subject to posttranslational cleavage near the amino-terminal end of the 
protein (Byeon et al. 1996; Byeon et al. 1998).  
 
SLC26A3 is expressed mainly in the apical surface of enterocytes in duodenum, ileum and colon 
(Byeon et al. 1996; Höglund et al. 1996; Haila et al. 2000; Jacob et al. 2002), but also in other 
extraintestinal tissues including eccrine sweat glands, intraprostatic seminal vesicles and trachea 
(Haila et al. 2000; Wheat et al. 2000).  In addition, SLC26A3 expression pattern is suggested to be 
dependent on the differentiation status of the tissue (Antalis et al. 1998; Haila et al. 2000). In 
inflammatory bowel disease and ischemic colitis, expression of SLC26A3 mRNA remains similar 
to histologically normal colon epithelium, but the protein localizes deeper in crypts (Antalis et al. 
1998; Haila et al. 2000).   
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Heterologous expression systems have established SLC26A3 as an anion exchanger that transports 
SO42-, Cl- and oxalate (Silberg et al. 1995; Byeon et al. 1998; Melvin et al. 1999; Moseley et al. 
1999). The SLC26A3 cRNA injected Xenopus oocytes demonstrated Na+-independent DIDS-
sensitive sulfate and chloride uptake. Similarily, Sf9 insect cells infected with the SLC26A3 
recombinant baculovirus induced increase in sulfate uptake. The mouse slc26a3 functions as a Cl-
/HCO32- exchanger with features compatible also with a Cl-/OH- exchanger (Melvin et al. 1999).  
Furthermore, the apical anion exchanger in rabbit and rat duodenum has recently been shown to 
mediate DIDS-sensitive Cl-/Cl-, HCO32-/Cl-, SO42-i/Cl-o and Cl-i/SO42-o exchange (Jacob et al. 2002), 
corresponding well with the transport characteristic of SLC26A3. Altogether, these findings 
demonstrate that SLC26A3 mediates an apical electroneutral Cl-/HCO32- exchange in different 
tissues. 
 
In CLD, the Cl-/HCO3- exchange is absent or defective, causing a severe intestinal Cl- absorption 
defect (Holmberg et al. 1975).  Large amounts of Cl- are lost in the stools, and the patients develop 
hypochloremia.  The respective defect in HCO3- secretion leads to metabolic alkalosis and the 
acidification of intestinal content, which further inhibit the absorption of Na+ through Na+/H+ 
exchanger.  In the intestine, the high luminal electrolyte contents leads to diarrhoea by osmotic 
mechanisms. Na+ and water losses cause secondary hyperaldosteronism and K+ wastage, leading to 
both hyponatremia and hypokalemia (Holmberg 1986). 
 
Congenital chloride diarrhoea is a recessively inherited disorder of intestinal electrolyte absorption 
involving Cl-/HCO3- exchange (Darrow 1945; Gamble et al. 1945).  The main clinical feature of 
CLD is prenatal onset of watery diarrhoea, leading to polyhydramnios prematurity (Holmberg et al. 
1975).  Newborn babies have distended abdomen, absence of meconium, chronic diarrhoea and they 
fail to thrive. They develop hyperbilirubinemia, dehydration and metabolic alkalosis, and severe 
electrolyte disturbances with hyponatremia, hypokalemia and hypochloremia. The disease is often 
fatal if untreated by oral compensation of fluid and electrolyte losses (Holmberg 1986).  
 
Since the identification of the SLC26A3 gene, 27 different mutations have been found in different 
populations and sporadic cases. The spectrum of the mutations includes transversions, transitions, 
insertions, deletions and two genomic rearrangements (Höglund et al. 1996; Etani et al. 1998; 
Höglund et al. 1998; Höglund et al. 1998; Höglund et al. 2001). In Finland and Saudi-Arabia, a 
single major mutation in each country (V317del and G187, respectively) has been shown to account 
for over 90% of the CLD-associated chromosomes (Höglund et al. 1998). However, the functional 
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characterization of the mutants remains still to be determined. Only the Finnish mutation, V317del, 
has been confirmed by a functional analysis in Xenopus oocytes, demonstrating a defective chloride 
and sulfate transport (Moseley et al. 1999).    
 
 
 
Figure 5. Predicted domain structures of the SLC26A3 protein and distibution of mutations. Three 
alternative models with 10 (A), 12 (B) or 14 (C) transmembrane segments have been presented. 
Location of some of the known mutations have been indicated with symbols as follows: point 
mutations are circles, insertions are triangles pointing upward and deletions are triangles pointing 
down, missense mutations are indicated with black symbols and splice site mutations with striped 
symbols. Potential N-linked glycosylation sites are indicated by G (Kere et al. 1999). 
 
2.2.4. Defects in SLC26A4 chloride/iodide exchanger cause deafness with goitre   
Pendred syndrome is an autosomal recessive disorder of congenital sensorineural hearing loss often 
with goitre (Pendred 1896). The deafness is present typically at birth, but can be variable in its 
expression, sometimes appearing during childhood.  The hearing loss is generally profound and 
Pendred syndrome patients have structural malformations of the inner ear, the most common feature 
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of which is an enlarged endolymphatic duct (Cremers et al. 1998; Usami et al. 1999; Reardon et al. 
2000).  Even more variable in its presentation is the thyroid disease, goitre. It can develop at any 
age, but may be totally absent in some affected individuals (Johnsen et al. 1986). The goitre is often 
associated with an abnormal release of iodide from the thyroid, which can be analysed by a 
perchlorate discharge test (Sheffield et al. 1996).  
 
Since the syndrome has been suggested to account for 10% of hereditary hearing loss, the 
identification of the Pendred syndrome gene has been of special interest (Fraser 1965). The 
identification of the gene was succeeded by positional cloning efforts (Coyle et al. 1996; Sheffield 
et al. 1996; Everett et al. 1997). Finally, the identification of independent mutations confirmed that 
Pendred syndrome is caused by mutations in a single gene, named PDS (Everett et al. 1997).  The 
PDS gene consists of 21 exons, encoding a 780-amino acid transmembrane protein, pendrin.  The 
PDS gene has been positioned tail-to-tail to the SLC26A3 gene on 7q22-q3.11. Its sequence is well 
conserved with the SLC26A2 and A3 sequences suggesting both evolutionary and functional 
relationships. Currently, the PDS gene has been designated as SLC26A4. 
 
Expression of SLC26A4 is thought to be responsible for the iodide transport in the thyroid as well 
as the formation and function of the inner ear.  In human, SLC26A4 is expressed at highest level in 
thyroid tissue, but it has been detected also in kidney, brain, placenta, cochlea, endometrium, lung, 
breast, prostate and testis (Everett et al. 1997; Everett et al. 1999; Royaux et al. 2000; Lacroix et al. 
2001; Royaux et al. 2001; Suzuki et al. 2002). In thyroid gland, SLC6A4 is present exclusively in 
the apical membrane of the follicular epithelium in is regulated by thyroglobulin (Royaux et al. 
2000). In the mouse inner ear, SLC26A4 has been localized to discrete areas, including regions 
thought to play a key role in fluid transport (Everett et al. 1999). Thus, the expression pattern of 
SLC26A4 points to a likely role for SLC26A4 in the thyroid and inner ear physiology defective in 
Pendred syndrome. 
 
Heterologous expression systems have revealed that SLC26A4 can transport several different 
anions such as chloride, iodide, formate and nitrate, but not sulfate (Kraiem et al. 1999; Scott et al. 
1999; Bogazzi et al. 2000; Scott and Karniski 2000). Specifically, iodide is taken up by thyroid via 
the sodium/iodide symporter (NIS) in the basolateral membrane of follicular thyrocyte (Fig. 6).  
Subsequently, it has been postulated that iodide is transported across thyrocyte´s apical membrane 
by SLC26A4 into the colloid and is then incorporated into thyroglobulin.  Therefore, the functional 
activities of SLC26A4 correlate closely with previous findings showing that iodine organification 
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has been altered in thyroid cells obtained from a Pendred syndrome patient. Defective iodine 
organification results in goitre, with various degrees of hypothyroidism (Scott et al. 1999).  
However, recent expression and mutational studies point toward some redundancy in the role of 
SLC26A4 in the thyroid. It has been shown that SLC26A4 content of thyroid tissue does not vary 
with the functional activity of the gland in terms of iodine accumulation and utilization (Porra et al. 
2002). Furthermore, some mislocalizing SLC26A4 mutants lacking the iodide transport function, do 
not associate with the thyroid pathology (Taylor et al. 2002), suggesting that there may be an 
alternative iodide transporter to facilitate efflux across the apical membrane of the thyroid.     
 
Recently, SLC26A4 has also been proposed to function as a Cl-/OH- and Cl-/HCO3- exchanger in 
cortical part of the kidney.  However, PS patients have not reported to develop overt acid-base 
disturbances or other renal manifestations, suggesting compensatory activities of other transporters 
in kidney (Royaux et al. 2001; Soleimani et al. 2001).    
 
 
SLC26A4 
Figure 6. SLC26A4 functions as a 
Cl-/I- exchanger in thyroid tissue 
(modified from Everett and Green 
1999).  
 
More than 50 independent SLC26A4 mutations, distributed throughout the coding sequence, have 
been characterized as causing Pendred syndrome and nonsyndromic deafness (Everett et al. 1997; 
Coyle et al. 1998; Li et al. 1998; Coucke et al. 1999; Usami et al. 1999; Reardon et al. 2000; 
Campbell et al. 2001; Gonzalez-Trevino et al. 2001; Lopez-Bigas et al. 2001). Most mutations are 
missense, with a smaller number of insertions, deletions, frameshift, and splice site mutations. 
Although most mutations are related to Pendred syndrome (Coyle et al. 1998; van Hauwe et al. 
1998), some of mutations associate with deafness without goitre, suggesting that the gene can 
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account for a broader spectrum of deafness than just Pendred syndrome (Usami et al. 1999).  This 
notion is further supported by the presence of residual SLC26A4 function associated with some of 
mutations in deaf patients without goitre (Scott and Karniski 2000).   
 
Targeted disruption of mouse slc26a4, which removed exon 8 of the gene, has also provided 
important clues about the etiology of deafness in Pendred syndrome (Everett et al. 2001). The 
possible role of SLC26A4 in the inner ear has been unclear, and it has been hypothesized that the 
chloride transport function of SLC26A4 is important in the homeostasis of the endolymph with 
ionic imbalance potentially responsible for auditory developmental malformation. The slc26a4-/- 
mice develop early-onset, profound deafness and display structural malformations in the inner ear, 
similar seen in Pendred syndrome patients. The inner ears of these knockout mice manifest severe 
endolymphatic dilatation, degeneration of sensory hair cells as well as other malformations. 
However, the slc26a4-/- mice showed a complete absence of any thyroid pathology, resembling 
patients with non-syndromic deafness associated with PDS-mutations (Everett et al. 2001).     
 
2.2.5. The SLC26 family is structurally different from the SLC4 family 
The SLC26 family is structurally different from the SLC4 family.  Although the genomic structures 
with about 20 exons resemble each other, the proteins differ completely at amino acid level: any 
apparent homologous regions cannot be found. In addition, the amino acid sequences of the SLC4 
members are nearly two times longer than those of the SLC26 proteins.  
 
The overall secondary structure of the proteins resembles more each other, since both families 
encode typical ion transporters with a hydrophopic membrane domain of 10-14 transmembrane 
segments associated with the hydrophilic N- and C-terminal tails.  However, SLC4 members have a 
large interactive cytoplasmic N-terminus and only a short cytoplasmic C-terminus, while the 
situation is conversed in the SLC26 family. They contain usually a short N-terminus and a large 
hydrophilic C-terminus, which provides interaction sites for cytoplasmic proteins.  Furthermore, the 
SLC4 proteins have been observed to function in oligomeric forms and heterozygous mutations 
have been associated with diseases. In contrast, the members of SLC26 family are all related to 
recessive diseases and the heterozygotes carriers have been asymptomatic, suggesting that the basic 
functional unit is monomeric. 
 
Despite these many structural differences, both families share a significant functional identity. The 
proteins are able to induce a Na+-independent anion exchange activity, and their anion specificity 
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and sensitivity for inhibitors resemble also each other. These findings raise an intriguing question 
about the fundamental structural features required for anion transport beyond these two structurally 
different families. Comparison of the structure-function relationships as well as the regulation of the 
proteins utilizing naturally occurring and created mutants will help to answer the question. 
Moreover, identification of novel structural homologs with new properties or diseases associations 
might also help to understand the anion transport physiology.  
 
In a search for the new SLC26 members, we utilized the rapidly accumulating genomic sequences 
in databases (Kere et al. 1999). The sequences of the first eukaryotic species, Saccharomyces 
cervisiae and Chaenorhabditis elegans had recently been annotated in public databases. A 
homology comparison with known family members revealed that the SLC26 family forms a large 
group of multispecific carriers present among bacteria, yeast, fungi, plants and animals (Kere et al. 
1999). Of interest, seven different genes were identified in plants such as Arabidopsis thaliana and 
animals such as C. elegans. Thus the human SLC26 gene family with three known members was 
likely to expand, and the still unknown genes might relate to new physiological processes or 
diseases.   
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3. AIMS OF THE CURRENT STUDY 
 
A growing interest in the SLC26 family was stimulated by the involvement of the first three 
members, SLC26A2-A4, in phenotypically different recessive diseases.  Futhermore, a homology 
search revealed that SLC26 family is well conserved across taxonomic span, including seven 
putative members in the first fully sequenced animal, C. elegans. This prompted us to hypothesize 
that more than three genes with important physiological functions or disease associations might 
exist also in human.  The principal goal of this study was thus to expand the SLC26 family and to 
characterize its novel members.   
 
In addition, as an example of the physiological role of ion transporters in pathophysiological states, 
we analysed how intestinal inflammation affects the expression of three major transporters of 
intestinal salt transport, SLC26A3 (Cl-/HCO3--exchanger), SLC9A3 (Na+/H+-exchanger) and CFTR 
(Cl--channel), to understand the pathophysiology of diarrhoea in ulcerative colitis.  In inflamed 
colonic mucosa, the equilibrium between absorptive and secretory functions for electrolyte and 
water transport is disturbed.  All three transporters do likely play in concert with each other, and 
their functional defects have been associated with diarrhoeal diseases.  Therefore, putative changes 
in the expression or function of the transporters might contribute to diarrhoea, which is a prominent 
symptom of ulcerative colitis.  
 
These starting points of the study led to the following aims:  
- to identify and map new candidates to the SLC26 family 
- to clone and characterize the new genes  
- to establish the expression pattern and the preliminary function of the new genes  
- to analyse the effects of intestinal inflammation on expression of SLC26A3, SLC9A3 and 
CFTR in ulcerative colitis  
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4. MATERIALS AND METHODS 
 
4.1. Computational sequence analysis (I-III) 
New homologs were searched by the human SLC26A2, SLC26A3, SLC26A4 nucleotide and 
protein sequences against different databases with BLASTP, BLASTX, TBLASTN, TBLASTX and 
FastA algorithms (Pearson 1994; Altschul et al. 1997; Zhang et al. 1997). GENSCAN, FGENES, 
and GRAIL2 were used to predict the coding exons from genomic clones (Xu et al. 1994; Solovyev 
et al. 1995; Burge and Karlin 1997). Multiple sequence alignment was done by ClustalW 
(Thompson et al. 1994) and GENEDOC programs (http://www.cris.com/ ~Ketchup /genedoc.shtml) 
or by ClustalX and BoxShade Server 3.21 (http://www.ch.embnet.org/ software/ BOX_form.html). 
Transmembrane topologies of the SLC26A6-A9 proteins were predicted by the TMHMM (Krogh et 
al. 2001) and PSIpred programs (Jones et al. 1994). Putative N-glycosylation sites were analysed by 
the PROSITE program (Bairoch et al. 1997). 
 
4.2. Chromosomal mapping by radiation hybrids (I) 
Chromosomal locations were assigned by PCR with gene specific primers using the GeneBridge 4 
Radiation Hybrid and Stanford G3 panels (Research Genetics, Inc, Huntsville, Alabama). PCR 
products were run on 2% agarose/EtBr gel and results were analysed according to the publicly 
available RH-mapper servers at http://www-genome.wi.mit.edu/cgi-bin/contig/rhmapper.pl and 
http://www-shgc.stanford.edu/RH/rhserver formnew.html. 
 
4.3. Rapid amplification of cDNA ends, PCR assays and sequencing (I-III) 
The coding regions of each gene were assembled from several overlapping PCR fragments, which 
were amplified by gene specific primers designed to GENSCAN-predicted exons (for details see 
Table 5 below).  The overlapping fragments were amplified by PCR from the first strand cDNAs of 
human kidney, testis and lung.  The first strand cDNAs were synthesized from 1 µg poly(A)+ RNA 
(Clontech, Palo Alto, USA) by RT-PCR using the SMART RACE cDNA Amplification Kit 
(Clontech). The SMART RACE method was used for amplification of the 5´ and 3´ ends of the 
cDNAs.  Furthermore, the cloning of the 3´ends of the genes was also accomplished by PCR with 
primers designed to the regions, which matched the expressed sequence tags (EST) annotated in 
GenBank.  PCR products were run on agarose gels, excised and purified for sequencing or 
subcloned by TOPO-TA system (Invitrogen) before sequencing. The PCR products were sequenced 
using dye-terminator chemistry (Sanger et al. 1977) and an automated sequencer (ABI 373A, 
Applied Biosystems).   
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4.4. Polyacrylamide gel electrophoresis analysis of single residue polymorphism (I) 
During the cloning of the SLC26A6 gene several alternative sequences were found, suggesting 
alternative splicing events. First strand cDNA was synthesized from 1 µg of human kidney total 
polyA RNA (Clontech) by the SMART RACE cDNA Amplification Kit (Clontech) according to 
manufacturer´s instructions. To separate a putative splicoform of SLC26A6, missing three base 
pairs in the beginning of exon 17, the region was amplified by PCR with exon 16 and 17 specific 
primers. The PCR products were separated on a 6% polyacrylamide gel and visualized by silver 
staining.  The polymorphism was also verified by cloning and sequencing the PCR fragments. One 
hundred genomic control DNA samples were analysed in the same way to exclude possible genetic 
polymorphism as a reason for variation.   
 
4.5. Expression analysis from cell lines (I-III) 
The expression of SLC26A6 and SLC26A9 genes was analysed from different cell lines by RT-
PCR. Expression of SLC26A6 was analysed from human embryonal kidney (HEK) 293 and two 
human pancreatic duct cell lines, Capan-1 and Capan-2 (ATCC, Manassas, USA) and the 
expression of SLC26A9 from two human lung-specific epithelial cell lines, NCI-H358 and A549, 
from bronchoalveolus and alveolus, respectively. The HEK 293, NCI-H358 and A549 cells were 
grown in Dulbecco´s Eagle Medium (Gibco BRL, Gaithersburg, MD) with 50 U/ml penicillin, 2 
mM sodium pyruvate, 2 mM glutamine and 5% fetal bovine serum. Capan-1 cells were grown in 
Iscove´s modified Dulbecco´s medium with 4 mM L-glutamine, 50 µg/ml penicillin and 20% fetal 
bovine serum and Capan-2 cells in McCoy´s 5a medium with 1,5 mM L-glutamine, 5050 µg/ml 
penicillin and 10% fetal bovine serum. The cells were grown at 37°C in 5% CO2 atmosphere to 
achieve full confluence. Total RNAs were isolated according to QIAGEN RNA Isolation Kit and 
the first strand cDNAs were synthesized from 1-2 µg of total RNA by the SMARTRACE cDNA 
Amplification Kit (Clontech). The SLC26A6 and A9 genes were amplified by PCR with gene 
specific primers and analysed by running on an agarose gel. The identity of PCR products was 
verified by sequencing.    
 
4.6. Expression analyses by Northern blots and PCR panels (I-III) 
Northern analysis was done using the Clontech (Palo Alto, USA) MTN Northern blots (MTN 7780-
1 and MTN 7760-1). A1984-bp PCR amplified probe corresponding to nt 198 to 2181 of SLC26A7, 
a 551-bp probe corresponding to the 5´sequence from nt 156 to 707 of SLC26A8 and a 2362-bp 
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probe corresponding to the open reading frame sequence from nt 115 to 2476 of SLC26A9 were 
radiolabelled with 32PdCTP with Rediprime Kit (Amersham) according to manufacturer´s 
instructions. The specific probes were hybridized to filters for different periods, and after washes 
the results were visualised by autoradiography performed on X-ray films.  PCR analyses were done 
using Clontech´s multiple tissue cDNA panels I and II (K1420-1 and K1421-1) with the gene 
specific primers.  The PCR results were analysed on agarose gel. 
 
4.7. In situ hybridization (I-II) 
Formalin fixed, paraffin-embedded specimens of normal adult human kidney and testis were 
obtained from the Department of Pathology, Haartman Institute, University of Helsinki. A 471-bp 
fragment corresponding to nucleotides 621-1091 of SLC26A6 cDNA and a 538 bp fragment 
corresponding to positions 1629-2166 of the SCL26A8 cDNA were amplified by PCR and used to 
transcribe sense and anti-sense RNA probes (Saarialho-Kere et al. 1994). All sections were 
pretreated with 1 µg/ml of proteinase K and washed in 0,1 M triethanolamine containing 0,25 % 
acetic acid. Sections were hybridized with 35S-labeled probes (4 x 104 cpm/ml of hybridization 
buffer) at 52-55°C in a humidified chamber for at least 18 hours. Slides were then washed under 
stringent conditions, including treatment with RNAse A to remove unhybridized probe (Prosser et 
al. 1989) before dipping to LM-1 emulsion (Amersham, Buckinghamshire, England). After 10-54 
days of autoradiography, the photographic emulsion was developed, and the slides were 
counterstained with hematoxylin and eosin. The sense RNA probe was used as a negative control. 
 
4.8. Antibodies (I-IV) 
Specific antibodies were raised in rabbits against the amino-terminal, MDLRRRDYHMERPLLN 
QEHL, and carboxy-terminal amino acids, TFALQHPRPVPDSPVSVTRL, corresponding to the 
nucleotides 252-312 and 2405-2465 of the SLC26A6 cDNA sequence (AF279265), respectively. 
Similarily, antisera were raised also against the synthetic peptides SHIHSNKNLSKLSDHSEV for 
SLC26A7, VEEVWLPNNSSRNSSPGLPD for SLC26A8 and ELSLYDSEEDIRSYWDLEQE for 
SLC26A9, corresponding to amino acids 639-656, 680-699 and 758-777, respectively. Two rabbits 
were immunized per each peptide and peptide synthesis and antibody production were purchased 
from Sigma-Genosys Ltd (London Road, Pampisford, Cambridge). SLC26A6 antibodies were 
purified from whole serum by affinity chromatography with the peptide coupled to N-
hydroxysuccinimide-Sepharose 4B according to the manufacturer's instructions (Amersham 
Pharmacia Biotech).  The C-terminal antiserum was raised in rabbits against the synthetic peptide 
corresponding to nucleotides 2375-2416 of the published SLC26A3 sequence (GenBank 
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L02785)(Research Genetics, Huntsville, Ala., USA). The cloned region was produced and purified 
as GST (glutathione-S-transferase) fusion protein according to the manufacturer’s instructions 
(Amersham Pharmacia Biotech). The purified fusion protein was used then as antigen in the 
immunization of two rabbits (Animal Core Facility, Viikki Biocenter, University of Helsinki). 
Preimmune sera were collected before the first immunizations. A total of five immunizations were 
performed at three weeks´ intervals using ~400 µg of the GST fusion protein mixed 1:1 with 
Freund´s adjuvant. After the immunization, rabbits were bled and the sera were divided to small 
aliquots for preservation at -20°C.  The specificity of the anti-SLC26A6 antibodies was analyzed by 
western blotting with SLC26A6-transfected COS-1 cells, and by in vitro translation of the protein 
according to the manufacurer´s instructions (TNT T7 Quick Coupled Transcription/Translation 
System, Promega).  COS-1 cells grown on 6 cm plates were transiently transfected using Fugene6 
liposomes (Roche Molecular Biochemicals) with either the SLC26A6a clone (5 µg) or water as a 
control, following manufacturer´s instructions.  Three days after the transfections, the cells were 
lysed in 500 µl of boiling Laemmli sample buffer (Pharmacia) with 5% β-mercaptoethanol and 
separated by running on a 9% polyacrylamide gel before transferred electroforetically to a Hybond 
C-extra membrane (Amersham). The non-specific protein binding sites were saturated with 5% 
milk in PBS, 0.2% Tween-20 before the proteins were detected by the antibodies. Appropriate 
dilutions of the primary antibodies were determined by immunoblotting. Horseradish peroxidase 
conjugated goat anti-rabbit IgG (Sigma) was used as a secondary antibody. Preimmune sera in the 
same concentrations were used as controls. The protein bands were visualized by chemiluminescent 
reaction and the signals were recorded by exposure to an X-ray film (Fuji).   
 
4.9. Immunohistochemistry (I,II,IV) 
Formalin fixed, paraffin-embedded specimens of normal adult human kidney and pancreas were 
used for immunohistochemistry. For pre-treatment, deparaffinized slides were treated at 100°C in 
microwave oven in 10 mM citrate buffer (pH 6.0) for 8 min and endogenic peroxidase activity was 
inactivated by 0.3% H2O2 /metanol at 25°C for 30 min. Appropriate dilutions of the anti-SLC26A6-
A9 or CFTR sera were used (diluted 1:50-1:2000), and immunostaining was done according to the 
VECTASTAIN Elite ABC Kit (Vector Laboratories, Inc., Burlingame, CA). Diaminobenzidine 
(DAB) was used as the chromogenic substrate and slides were counterstained by Mayer´s 
hematoxylin. Preimmune serum was used as negative control for parallel sections. 
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4.10. Functional transport measurements in Xenopus laevis oocytes (II-III) 
The animal experiments were performed by the author in the laboratory of Dr. Daniel Markovich, 
University of Queensland, Brisbane, Australia.  Mature Xenopus laevis females were purchased 
from the African Xenopus Facility C.C., Noordhoek, South Africa. Stage V and VI oocytes from X. 
laevis were maintained at 17°C in modified Barth's solution (88 mM NaCl, 1 mM KCl, 0.82 mM 
MgSO4, 0.4 mM CaCl2, 0.33 mM Ca(NO3)2, 2.4 mM NaHCO3, 10 mM HEPES/Tris, pH 7.4, 
gentamycin sulfate 20 mg/l). Oocytes were injected with either 50-100 nl of water (control) or 7-12 
ng of SLC26A7-A9 cRNA using a Nanojet automatic injector (Drummond Scientific Co., 
Broomall, PA, USA). The cDNA sequences of the SLC26A6a, SLC26A6c, SLC26d, SLC26A6adel 
and SLC26A6cdel were amplified by PCR and subcloned to pCRII plasmids (Invitrogen). 
A specific antisense primer (5'-CTA GAC CGA AAC AGG GCT GTC GGG GAC-3') missing the 
last nine bases but including a native stop codon was generated to delete the PDZ interaction motif 
(TRL) from SLC26A6adel and SLC26A6cdel contructs. The clones were verified by sequencing. 
For cRNA synthesis, plasmids were linearized by NotI digestion and transcribed in vitro using T7 
RNA polymerase (Promega) and the resulting capped cRNAs were resuspended in water before use. 
Similarly, for cRNA synthesis, pcDNA3.1:SLC26A7 or pcRII:SLC26A7, pcDNA3.1:A8 or 
pNKS2:SLC26A8 and pcRII:SLC26A9 plasmids were linearized by EcoRV, NotI or XhoI 
digestions; the cDNAs were in vitro transcribed using T7 or SP6 RNA polymerases (Promega) and 
the resulting capped cRNA was dissolved in MilliQ water before use. Transport of 35S-sulfate, 36Cl- 
-chloride and 14C-oxalate uptake was performed three days after injection. Briefly, 10 oocytes (per 
data point) were washed at room temperature for 1-2 min in solution A (115 mM sodium gluconate, 
2.5 mM potassium gluconate, 4 mM calcium gluconate, 10 mM HEPES/Tris pH 7.4) or solution B 
(100 mM choline chloride, 4 mM KCl, 2 mM CaCl2, 2 mM MgCl2 and 20 mM Hepes/Tris, pH 7.5), 
then placed into 100µl of solution A containing 2.5 mM NaCl with 36Cl- or 0.1 mM oxalate with 
14C-oxalate 2-5 µCi/ml, or into 100 µl solution B containing 0.1 mM K2SO4 with 35SO42- 10 
µCi/ml or (New England Nuclear Radiochemicals) for 30-60 min at room temperature. The oocytes 
were washed 4 times with ice-cold solution B, lysed with 4% SDS, dissolved in scintillant (BCS, 
Amersham) and counted by liquid scintillation spectrometry.  Inhibition of the sulfate uptake of 
SLC26A6 isoforms was performed by adding 1 mM DIDS to the uptake solution B.  For the 
bicarbonate experiment, the standard 100mM NaCl uptake solution was replaced with 100 mM Na 
bicarbonate. Inhibition of the sulfate uptake of SLC26A9 was performed by adding either 1 mM 
DIDS, 5 mM thiosulfate, 5 mM oxalate or 5 mM glucose to the uptake solution B.  All isotopes 
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were purchased from New England Nuclear Radiochemicals.  Statistical analyses of the transport 
results were performed using the prism statistic package, version 3.0 (Graphpad software Inc. San 
Diego, California, USA).  The degree of statistical significance between two groups was calculated 
using the unpaired t-test, with p<0.05 considered significant.   
 
4.11. RNase protection analysis  (III) 
The presence of the SLC26A6 isoforms was analyzed by the ribonuclease protection technique 
according to the Direct Protect kit (Ambion Inc., Austin, TX) with two different RNA probes. A 
PCR fragment of 300 bp (bases 774-1075 in SLC26A6 cDNA, GenBank AF297659) to detect the 
SLC26A6a and A6c, and another fragment of 363 bp (bases 2085-2316 +131 bp from the end of 
intron 16 to detect SLC26A6a and A6d were amplified from human kidney cDNA (Clontech), 
purified and subcloned to pCRII-TOPO (Invitrogen) to utilize the T7 and SP6 priming sites in the 
generation of the transcription templates. The orientation of the fragments was verified by 
sequencing. The transcription templates were amplified by PCR using the same forward primers as 
used in the previous PCR with T7 or SP6 oligo as an antisense primer. Antisense RNAs of 396 nt 
(probe 1) and 446 nt (probe 2) were transcribed with T7 or SP6 RNA polymerase by the Maxiscript 
SP6/T7 Kit (Ambion) in the presence of [ -32P]UTP, and hybridized with 10 µg of total, 1 µg polyA 
human kidney RNA, or 1 µg polyA human lung RNA. After an overnight hybridization, unpaired 
RNA was degraded by treatment with RNase Cocktail at 37°C for 30 min followed by isopropanol 
precipitation. Protected RNA fragments were fractionated by 5% SDS-PAGE containing 6 M urea 
and visualized by autoradiography.  
 
4.12. Cell transfection and immunofluorescence (III) 
Topologies of the SLC26A6 isoforms were analyzed in transfected permeabilized and non-
permeabilized COS-1 cells by immunofluorescence microscopy. The cDNAs of the SLC26A6a, 
SLC26A6c and SLC26d were amplified by PCR and subcloned to eukaryotic pcDNA3.1/V5/His-
TOPO plasmid (Invitrogen). The same primers were used for template production as in the splicing 
analysis. For immunofluorescence staining, COS-1 cells plated on glass coverslips were transiently 
transfected using Fugene6 (Roche Molecular Biochemicals) with either the clones or water as a 
control, following manufacturer´s intructions. The cells were grown as described above. After 48 h, 
the cells were fixed with 3% paraformaldehyde in phosphate-buffered saline (PBS, 0.14 M NaCl in 
10 mM sodium phosphate buffer, pH 7.4). After fixing, the coverslips were washed two times with 
PBS and permeabilized with 0.1% Triton in PBS 30 min continuing then with blocking. If not 
permeabilized, the cells were washed after fixation and then blocked with 3% goat serum in PBS 
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for 1 h. Affinity-purified antibodies were then added (1-5 µg/ml) in 1% goat serum in PBS and 
incubated at room temperature for 1 h. After three washes with 3% goat serum in PBS, fluorescein 
isothiocyanate (FITC)-conjugated anti-rabbit IgGs (Sigma) were added and incubated for 1 h. 
Coverslips were then washed 5 times with PBS and mounted on glass slides using Immu-mount 
medium (Shandon, Pittsburgh, PA).  Sections were examined and images were acquired on a Leica 
immunofluorescence microscopy. 
 
4.13. In vitro binding assays (III) 
The protein binding assays were performed in the laboratory of Dr. Georg Lamprecht and Ursula 
Seidler at the University of Tubingen, Germany. The full-length cDNA sequences of the SLC26A6 
and SLC26A6del in the pcDNA3.1/v5/his-TOPO plasmid were digested by HindIII and EcoRV and 
subcloned into pinPoint (Promega); these constructs were called Biotin-26A6-C-terminus and 
Biotin-26A6del-C-terminus. To express biotinylated fusion proteins, an overnight culture (pinPoint 
construct in E.coli NM522) was diluted 1:100 in LB plus 50 µM Biotin and after 2.5 h 0.8 mM 
IPTG was added. After another 4.5 h, bacteria were spun down and sonicated in 100 mM NaCl, 100 
mM Na2HPO4, pH 7.4 in a Branson sonifier. The material was finally spun at 20,000 g for 20 min 
and the supernatant saved.  His-tagged fusion proteins of full length NHERF (amino acids 1-367) 
and E3KARP (1-337) as well as their individual PDZ domains (NHERF-PDZ1: 1-153, NHERF-
PDZ2: 159-346, E3KARP-PDZ1: 1-141, E3KARP-PDZ2: 130-311) and their C-termini (NHERF: 
266-368, E3KARP: 232-337) were expressed in pET30 (Novagen), affinity-purified under non-
denaturing conditions using Nickel-nitrilotriacetic acid (NTA) resin as suggested by the 
manufacturer (QIAGEN Inc.) and finally eluted in 1 M imidazol, 150 mM NaCl, 10 mM Na2HPO4, 
pH 8. The His-tag fusion protein constructs of NHERF and E3KARP (about 4 µg) were diluted in 
siliconized tubes in 1 ml of interaction buffer (200 mM NaCl, 100 mM NaH2PO4, pH 7.5) to 
decrease the imidazol to less than 15 mM. 1 µl (20 µl of 5% suspension supplied by the 
manufacturer) of magnetic NTA-Ni agarose beads (Qiagen) was added. After 1 h the beads were 
separated using a magnet and the supernatant was removed. The beads were blocked for 10 min 
using 2% BSA in interaction buffer. 500 µl of the cleared bacterial lysate of Biotin-SLC26A6-C-
terminus and Biotin-26A6del-C-terminus and 500 µl of 4% BSA (in interaction buffer) were added 
and the suspension was incubated for 4 h. The beads were washed 4 times with interaction buffer 
using the magnetic separator. Finally the bound material was eluted in 50 µl Laemmli sample buffer 
and separated on PAGE in the presence of SDS. After transfer, the nitrocellulose membranes were 
blocked with 3% BSA/TBS, and biotinylated proteins were detected using HRP-labeled 
Streptavidin and an ECL-detection system. 
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4.14. Real-time quantitative PCR (IV) 
Real-time quantitative PCR can be used for sensitive measurement of different RNA levels. In this 
relatively new quantitative PCR method, gene specific probes labeled with fluorescent dyes are 
cleaved by 5´-3´-endonuclease activity of Taq DNA polymerase (Taqman universal PCR master 
mix, Perkin-Elmer). Sequence-specific signals from the fluorogenic probes are generated during the 
PCR. The fluorescence emission is gathered via optic cables and CCD camera into the computer. 
The Sequence Detection System software analyzes the data by first calculating the contribution of 
each component dye to the experimental spectrum. The reporter signal (FAM, JOE or VIC) is then 
normalized to the fluorescence of an internal reference dye (ROX). The parameter Ct (threshold 
cycle) is defined as the fractional cycle number at which the reporter fluorescence generated by 
cleavage of the probe passes a fixed threshold above baseline. The sensitive fluorescence detection 
allows the threshold cycle to be observed when PCR amplification is still in the exponential phase, 
rather than the amount of PCR product accumulated after a fixed number of cycles. Measuring Ct 
and comparing it to the Ct of the control gene accomplish relative quantitation of the amount of 
target in unknown samples.  Adjacent colonic tissue samples were used for histological grading and 
RNA extraction. Total RNA was extracted from fresh tissues using RNeasy Mini Kit (Qiagen) and 
400 ng total RNA was further transcribed to cDNA with random hexamers (Taqman Reverse 
Transcription Reagents, Perkin-Elmer). Dilutions of the cDNA were used for real-time quantitative 
PCR (5´ fluorogenic nuclease assay) using Perkin-Elmer´s ABI Prism 7700 Sequence Detector 
System (23). The probes used were CCA ATC GAA TTC ATT ATG ACC GTG ATT GC for 
SLC26A3, ATG CAG TCT CTG GAG CAG CGA CGG for SLC9A3 and CAG AAG CGT CAT 
CAA AGC ATG CCA AC for CFTR. Primers were designed into exon-intron junctions to avoid 
amplification of genomic DNA. A S18 rRNA probe and primers were used as an endogenous 
control gene (S18 control kit, Perkin-Elmer). PCR conditions were: 2 min 50°C, 10 min 95°C and 
40 cycles of 15 sec 95°C, 1 min 60°C. The PCR assays were performed in separate tubes and 
relative quantitation of the SLC26A3, SLC9A3 and CFTR mRNAs was performed using the 
standard curve method according to the manufacturer’s instructions (PE Applied Biosystems, User 
Bulletin #2: ABI PRISM 7700 Sequence Detection System).  
 
4.15. Tissue samples and histological grading (IV) 
Altogether 30 peroperative tissue samples from 10 patients undergoing surgery for ulcerative colitis 
and 12 samples from 4 control individuals with non-inflamed colon mucosa were obtained from the 
Department of Surgery, Helsinki University Central Hospital by permission of the respective 
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Ethical Review Board. Inflamed colonic tissue samples were taken from two areas: those that 
macroscopically appeared normal and those demonstrating the highest degree of inflammation. 
Control tissue samples were taken from morphologically unaltered, uninflamed colonic mucosa of 
benign (tubular adenoma) or malignant (two adenocarcinomas) tumors at distant nonneoplastic area, 
as well as of diverticulosis. Tissue samples used for mRNA and protein analysis were taken from 
the same area as those samples used for histopathological analysis. Tissue samples were handled 
immediately after surgery on ice or snap frozen in liquid nitrogen before homogenization.  The 
samples for histological analyses were fixed in 10% neutral buffered formalin immediately after 
surgery. Formalin-fixed paraffin-embedded samples were prepared for histology and stained by 
hematoxylin-eosin for histological grading. The degree of inflammation was graded (Truelove and 
Richards 1956) on a four point scale; normal, (no significant inflammation, n=12); mild, (elevated 
number of mucosal leukocytes but intact epithelium, n=11); moderate, (aggregates of leucocytes 
with crypt abscesses and erosions but no ulceration of the epithelium, n=7); and severe (significant 
ulceration of the epithelium by mononuclear cell infiltrate, n=12). Histological grading was 
performed by a pathologist (Marja-Liisa Karjalainen-Lindberg, Dept. of Pathology) without 
knowledge of surgery or the endoscopic reports and experimental data.  
 
4.16. Immunoblotting (IV) 
Mucosal scrapings of human colon tissues were transferred to ice-cold lysis buffer (50 mM core 
buffer (Roche), 150 mM NaCl, 0,1 mg/ml phenylmethylsulfonyl fluoride, 1 µg/ml aprotin, 1 µg/ml 
leupeptin, 1% Nonidet P-40, 0,5% sodium deoxycholate). The lysed cells were homogenized by a 
syringe and needle followed by centrifugation at 12000 g at 4°C for 10 minutes. The supernatant 
was preserved for protein analyses.  Protein concentration was measured using the colorimetric 
Bradford protein assay (Bio-Rad Lab., Hercules, California, USA). Total proteins were separated by 
9% SDS-PAGE, and electroblotted onto Hybond C-extra membranes (Amersham Pharmacia 
Biotech, Uppsala, Sweden). Non-specific binding sites were saturated by incubating the membranes 
in a solution of 5% non-fat dry milk in PBS containing 0.1% of Tween-20. Appropriate dilutions of 
the primary antibodies were determined by immunoblotting, and biotin conjugated goat anti-rabbit 
IgG (Roche, Basel, Switzerland) was used as a secondary antibody in PBS. To visualize the protein 
bands by enhanced chemiluminescent reaction, membranes were incubated in dilution of 
horseradish peroxidase conjugated streptavidin (Roche). Computer assisted scanning densitometry 
(Biometra, BioDocAnalyze, Göttingen, Germany) was used to analyze the intensity of the 
immunoreactive bands in the autographs.  The optic densities were normalized to the amount of 
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protein in lane. Statistical significance between groups was analyzed by the nonparametric Kruskal-
Wallis test. 
 
4.17. Statistical analysis (IV) 
Statistical analyses were performed using the PRISM Statistic Package, version 3.0 (GraphPad 
Software Inc. San Diego, California, USA). The degree of statistical significance between two 
groups was calculated using the nonparametric Mann-Whitney U-test. Comparisons between three 
or more groups were performed using the Kruskal-Wallis test. The groups were considered different 
at a p value <0.05. In these cases, p values for comparisons between groups were calculated using 
Dunn´s multiple comparison as a nonparametric post-test. 
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5. RESULTS
5.1. Identification of seven novel human SLC26 members with distinct map positions and  
expression patterns (I-II) 
A homology approach using the public databases mainly through the NCBI BLAST server was 
utilized in a search for new members of the SLC26 family; much of the initial database work was 
done in 1998-1999, and only using publicly available sequences. Protein and nucleotide sequence 
homology searches with the three known human sequences SLC26A2-A4 (U14528, L02785 and 
AF030880, respectively) revealed several significant matches against ESTs and genomic sequences 
(BLASTX E-value >1e-20). The characterization of these new candidates was initiated by assigning 
the chromosomal locations using radiation hybrid panels and found matches to genomic clones 
deposited in GenBank. The coding regions of some candidates were expanded by sequencing the 
corresponding IMAGE clones.  In addition, the preliminary tissue distribution was determined 
using Clontech´s multiple tissue cDNA panels.  
 
Altogether, seven novel loci with tissue specific expression patterns were established including the 
human ortholog of rat slc26a1 gene (Table 2).  Subsequently, five of the candidates were cloned and 
characterized.    
 
Table 2. Summary of the new candidate members of the SLC26 family found by homology 
searches. 
Candidate 
sequences 
Length of the 
translated 
sequence  
Degree of amino 
acid homology  
Chromosomal 
location 
Major site of 
expression 
EST AW001016 130 aa 84% to rat 
slc26a1 
4p16.3 Liver, kidney, 
pancreas, brain 
EST AA411587 120 aa ~50% to 
SLC26A3 
3p21.3 Kidney, pancreas  
genomic PAC 
179N16 
~300 aa predicted ~50% to 
SLC26A3 
6p21.1 Testis 
EST AA992584 376 aa 48% to SLC26A2 8q23 Kidney, testis, 
placenta 
unspliced cDNA 
AL050358 
427 aa ~60% to 
SLC26A4 
12q13 Brain, other? 
EST AA348883 300 aa Homologous to 
insect and plant  
orthologs  
17q25 Ubiquitous 
genomic PAC 
clone RP11-370I5 
(AL360009) 
~500 aa predicted A match of E-
value=0.001 with 
SLC26A3  
1q32 Lung 
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5.2. Characteristics of the novel family members (I-III) 
After the mapping and identification of the new candidates, further studies concentrated on the 
characterization of the structure, expression and function of the SLC26A6-A9 genes.  In addition, 
the human ortholog of rat slc26a1 was mapped and cloned. Sequences have been submitted to 
GenBank and the nomenclature has been verified with the HUGO Nomenclature Committee. 
Subsequently, the new human genes have been designated SLC6A1 and SLC26A6-A11.  The 
characterization of SLC26A10 and A11 is still poorly known and continues. 
   
SLC26A1. Homology screenings found a human EST sequence (AW001016), which showed the 
highest homology (84%) to rat sulfate/anion exchanger, suggesting a putative ortholog for rat 
slc26a1. The identified EST sequence matched to a genomic sequence recently emerged in 
GenBank facilitating the cloning of the human SLC26A1 sequence (GenBank AF297659). 
Sequence analysis revealed that the SLC26A1 cDNA (~3.6kb) contains three exons and translates 
into a protein of 701 amino acids, which shares 77% sequence identity with rat slc26a1.  The 
murine slc26a1 gene was also characterized recently (Xie et al. 2002). Its predicted protein is 91% 
and 76% identical to the rat and human SLC26A1 proteins, respectively.  SLC26A1 shows the best 
sequence similarity to SLC26A2 within the SLC26 family (Fig. 8).  The gene maps to 4p16.3 and 
locates within another gene on the opposite strand encoding the enzyme α-L-iduronidase (IDUA).  
Initial expression analysis showed abundant expression in the liver, kidney, pancreas and brain, 
resembling that of the rat slc26a1 (Bissig et al. 1994; Markovich et al. 1994; Karniski et al. 1998).  
Thus SLC26A1 is likely to be the human counterpart of the rat slc26a1 gene because of its high 
sequence homology, resembling expression pattern and corresponding syntenic chromosome region 
with the rat and mouse slc26a1 genes. 
 
SLC26A6. The cloning of the putative new gene (EST AA411587) on 3p21.3 was accomplished by 
verifying the predicted exons in the human genomic clone. Sequence analysis revealed an open 
reading frame of 2217 bp encoding a 738 amino acid protein, which has been designated SLC26A6 
(GenBank AF279265).  The open reading frame of SLC26A6 is distributed across 20 exons ranging 
in size from 55 to 177 bp. Exon-intron boundaries obey the general AG-GT rule except for exon 15 
that ends to GC. Interestingly, 12 of 20 exons are exactly of the same size as those of the SLC26A3 
and SLC26A4 genes, which share 15 exons of similar size with each other.  The putative ATG 
translation start site is within the Kozak consensus sequence (Kozak 1987), and four in-frame stop 
codons precede that methionine. A 280-bp 3' untranslated region precedes the consensus 
polyadenylation signal AATAAA.   
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The SLC26A6 protein shows the best sequence similarity (56%) to SLC26A5 with a suggested 
function as a cochlear motor protein (Fig. 8).  Twelve-transmembrane structure with intracellular N- 
and C-terminal domains, suggested by the PSIpred program, resembles the topology predicted for 
the human SLC26A2 and SLC26A3 proteins (Kere et al. 1999).  ProfileScan analysis of the 
SLC26A6 protein sequence revealed two domains, which are also commonly shared within the 
other SLC26 family members (Table 4): Sulfate Transporter family domain (ST, predicted between 
aa ~200-500, PF00916) and Sulfate transporters and Antisigma-factor antagonists domain (STAS, 
between aa ~500-700, PS50801). The putative NTP-binding STAS domain suggests that anion 
transport could be regulated by intracellular nucleotides (Aravind and Koonin 2000).  In addition, 
C-terminus of the SLC26A6 protein (TRL) comprises the consensus PDZ interacting motif T/S-X-
Ф, in which Ф is a hydrophobic amino acid (Songyang et al. 1997).  The PDZ domain proteins play 
an essential role in maintaining the cell polarity and function (Caplan 1997; Aroeti et al. 1998; 
Fanning and Anderson 1999). 
 
Soon after the publication of the SLC26A6 gene, it was cloned also by another group (Waldegger et 
al. 2001).  However, their sequence differs in 5´ noncoding and coding region leading to an addition 
of 21 amino acids to the ultimate N-terminus of the gene.  The sequence flanking the putative 
translation start site contained a Kozak sequence. It is possible that this represents an alternative N-
terminal variant of SLC26A6, because our 5´noncoding region contained four in-frame stop codons, 
and also our putative translation initiation site resided within a Kozak consensus sequence.   
 
Similarly, two alternative 5´noncoding regions and translation sites with Kozak sequences were 
identified in the mouse slc26a6 gene (Xie et al. 2002).  Inclusion of the exon 1b in the longer 
slc26a6b transcripts results in a frameshift and a start codon within exon 2.  The predicted slc26a6b 
protein is thus 23 amino acids shorter than slc26a6a. The starts codons in exon 1a and 2 are both 
predicted Kozak sites. Slc26a6b is identical to the sequence of mouse chloride-formate exchanger, 
CFEX (Knauf et al. 2001), and corresponds to our SLC26A6, whereas the longer slc26a6a sequence 
corresponds to SLC26A6 reported by Waldegger et al.  The murine slc26a6 and human SLC26A6 
orthologs have similar genomic structures, but their share only 78% identity at the amino acid level 
(Xie et al. 2002). 
 
During the cloning of the full-length cDNA sequence of SLC26A6 (AF279265), several transcripts 
were repetitively obtained from RT-PCR amplifications and Northern blots, suggesting the presence 
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of alternatively spliced forms of the SLC26A6 gene.  We cloned and characterized two of them, 
named SLC26A6c and SLC26A6d.  For clone nomenclature, the isoforms were denoted 
SLC26A6a-A6d (A6b cloned by Waldegger et al. 2001) to portray the order of reporting these 
isoforms.  The presence of the SLC26A6a, SLC26A6c and SLC26A6d transcripts in human kidney 
and lung total RNA or mRNA were verified by ribonuclease protection assays.   
 
Sequence analysis of SLC26A6c and SLC26A6d revealed an open reading frame of 2100 bp and 
2016 bp encoding 699 and 671-amino-acid proteins, respectively (Fig. 7B). The topology of 
SLC26A6a, SLC26A6c and SLC26A6d analysed by PSIpred 2.0 method and hidden Markov model 
(TMHMM program) resulted in the prediction of 12-, 8- and 12-transmembrane and 10-, 8- and 10-
transmembrane helices with intracytoplasmic NH2 and COOH termini, respectively. 
 
Comparison of the nucleotide sequences of SLC26A6a and SLC26A6c revealed a 114 bp deletion 
within exon 6 and a 3 bp deletion in the beginning of the exon 17 produced by alternative usage of 
splice donor (GT) and acceptor sites, respectively.  This results in a deletion of amino acids 243 to 
281 and a glutamine residue (Q) at position 611 compared to SLC26A6a.  Thus the single residue 
polymorphism at position 611 found previously appeared to be a part of the SLC26A6c isoform 
(Fig. 7A). Deletion of the 38 residues results in the loss of two transmembrane domains (TMD #5 
and #6) and predicts an additional large extracellular domain after TMD #4.  A similar change has 
been described previously in the analysis of alternative splicing of rat liver-specific organic anion 
transporter-1 (Choudhuri et al. 2000). 
 
The SLC26A6d sequence retains an unspliced intron, intron 16 (892 bp), which includes several 
stop codons (Fig. 7A).  This leads to an alternative C-terminus of the protein compared with 
SLC26A6a, which may affect the regulation or function of SLC26A6d. Specifically, the C-terminus 
of SLC26A6d lacks the PDZ interaction motif, which is included in SLC26A6a and SLC26A6c. 
 
ATG st
op
ATG
ATG
st
op
st
op
SLC26A6a
SLC26A6c
SLC26A6d
1 2 3 4 5 6 7 8 11 12 13 14 15 16 17 18 19 209
 
-114 bp -3 bp
+Intron 16, 892 bp
 
 
Figure 7A. Genomic structures of the SLC26A6 isoforms.  
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SLC26A6a    1 MDLRRRDYHMERPLLNQEHLEELGRWGSAPRTHQWRTWLQCSRARAYALLLQHLPVLVWL
SLC26A6c    1 MDLRRRDYHMERPLLNQEHLEELGRWGSAPRTHQWRTWLQCSRARAYALLLQHLPVLVWL
SLC26A6d    1 MDLRRRDYHMERPLLNQEHLEELGRWGSAPRTHQWRTWLQCSRARAYALLLQHLPVLVWL
 
SLC26A6a   61 PRYPVRDWLLGDLLSGLSVAIMQLPQGLAYALLAGLPPVFGLYSSFYPVFIYFLFGTSRH
SLC26A6c   61 PRYPVRDWLLGDLLSGLSVAIMQLPQGLAYALLAGLPPVFGLYSSFYPVFIYFLFGTSRH
SLC26A6d   61 PRYPVRDWLLGDLLSGLSVAIMQLPQGLAYALLAGLPPVFGLYSSFYPVFIYFLFGTSRH
 
SLC26A6a  121 ISVGTFAVMSVMVGSVTESLAPQALNDSMINETARDAARVQVASTLSVLVGLFQVGLGLI
SLC26A6c  121 ISVGTFAVMSVMVGSVTESLAPQALNDSMINETARDAARVQVASTLSVLVGLFQVGLGLI
SLC26A6d  121 ISVGTFAVMSVMVGSVTESLAPQALNDSMINETARDAARVQVASTLSVLVGLFQVGLGLI
 
SLC26A6a  181 HFGFVVTYLSEPLVRGYTTAAAVQVFVSQLKYVFGLHLSSHSGPLSLIYTVLEVCWKLPQ
SLC26A6c  181 HFGFVVTYLSEPLVRGYTTAAAVQVFVSQLKYVFGLHLSSHSGPLSLIYTVLEVCWKLPQ
SLC26A6d  181 HFGFVVTYLSEPLVRGYTTAAAVQVFVSQLKYVFGLHLSSHSGPLSLIYTVLEVCWKLPQ
 
SLC26A6a  241 SKVGTVVTAAVAGVVLVVVKLLNDKLQQQLPMPIPGELLTLIGATGISYGMGLKHRFEVD
SLC26A6c  241 SK--------------------------------------LIGATGISYGMGLKHRFEVD
SLC26A6d  241 SKVGTVVTAAVAGVVLVVVKLLNDKLQQQLPMPIPGELLTLIGATGISYGMGLKHRFEVD
 
SLC26A6a  301 VVGNIPAGLVPPVAPNTQLFSKLVGSAFTIAVVGFAIAISLGKIFALRHGYRVDSNQELV
SLC26A6c  263 VVGNIPAGLVPPVAPNTQLFSKLVGSAFTIAVVGFAIAISLGKIFALRHGYRVDSNQELV
SLC26A6d  301 VVGNIPAGLVPPVAPNTQLFSKLVGSAFTIAVVGFAIAISLGKIFALRHGYRVDSNQELV
 
SLC26A6a  361 ALGLSNLIGGIFQCFPVSCSMSRSLVQESTGGNSQVAGAISSLFILLIIVKLGELFHDLP
SLC26A6c  323 ALGLSNLIGGIFQCFPVSCSMSRSLVQESTGGNSQVAGAISSLFILLIIVKLGELFHDLP
SLC26A6d  361 ALGLSNLIGGIFQCFPVSCSMSRSLVQESTGGNSQVAGAISSLFILLIIVKLGELFHDLP
 
SLC26A6a  421 KAVLAAIIIVNLKGMLRQLSDMRSLWKANRADLLIWLVTFTATILLNLDLGLVVAVIFSL
SLC26A6c  383 KAVLAAIIIVNLKGMLRQLSDMRSLWKANRADLLIWLVTFTATILLNLDLGLVVAVIFSL
SLC26A6d  421 KAVLAAIIIVNLKGMLRQLSDMRSLWKANRADLLIWLVTFTATILLNLDLGLVVAVIFSL
 
SLC26A6a  481 LLVVVRTQMPHYSVLGQVPDTDIYRDVAEYSEAKEVRGVKVFRSSATVYFANAEFYSDAL
SLC26A6c  443 LLVVVRTQMPHYSVLGQVPDTDIYRDVAEYSEAKEVRGVKVFRSSATVYFANAEFYSDAL
SLC26A6d  481 LLVVVRTQMPHYSVLGQVPDTDIYRDVAEYSEAKEVRGVKVFRSSATVYFANAEFYSDAL
 
SLC26A6a  541 KQRCGVDVDFLISQKKKLLKKQEQLKLKQLQKEEKLRKQAASPKGASVSINVNTSLEDMR
SLC26A6c  503 KQRCGVDVDFLISQKKKLLKKQEQLKLKQLQKEEKLRKQAASPKGASVSINVNTSLEDMR
SLC26A6d  541 KQRCGVDVDFLISQKKKLLKKQEQLKLKQLQKEEKLRKQAASPKGASVSINVNTSLEDMR
 
SLC26A6a  601 SNNVEDCKMMQVSSGDKMEDATANGQEDSKAPDGSTLKALGLPQPDFHSLILDLGALSFV
SLC26A6c  563 SNNVEDCKMM-VSSGDKMEDATANGQEDSKAPDGSTLKALGLPQPDFHSLILDLGALSFV
SLC26A6d  601 SNNVEDCKMM------------------VRLEVGKEVTAVSCRDAGSTCLMRNAMDPAAV
 
SLC26A6a  661 DTVCLKSLKNIFHDFREIEVEVYMAACHSPVVSQLEAGHFFDASITKKHLFASVHDAVTF
SLC26A6c  622 DTVCLKSLKNIFHDFREIEVEVYMAACHSPVVSQLEAGHFFDASITKKHLFASVHDAVTF
SLC26A6d  643 GSRVLRRWQEEWGGW---------------------------------------------
 
SLC26A6a  721 ALQHPRPVPDSPVSVTRL 
SLC26A6c  682 ALQHPRPVPDSPVSVTRL 
SLC26A6d  658 ----VRYSSGSVVICHRI 
 
 
  
Figure 7B. Comparison of the amino acid sequences of the SLC26A6 variants.  Predicted 
transmembrane segments are shadowed by grey.  
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SLC26A7. The SLC26-related EST AA992584 mapped to chromosome 8 was expanded and its 
sequence revealed an open reading frame of 1971 bp encoding a 656 amino acid protein designated 
SLC26A7 (GenBank Accession No. AF331521).  The SLC26A7 gene spans about 100 kb of 
genomic sequence and the open reading frame is distributed across 19 exons ranging in size from 55 
to 306 bp. A ~5250-bp cDNA of SLC26A7 includes four in-frame stop codons upstream the 
initiation methionine and a 3024-bp 3' untranslated region before the polyadenylation signal 
AATAAA. Moreover, several alternative polyA signals were identified at the 3´end of the 
SLC26A7 composite sequence, suggesting alternative polyadenylation of the gene.   
 
Consistent with this notion, the SLC26A7 gene was cloned from human high endothelial venule 
cells (HEVEC) (Vincourt et al. 2002). Alternative polyadenylation resulted in a shorter 2.9-kb 
cDNA, which encoded an identical 656-amino acid protein.  Furthermore, a C-terminal kidney-
specific variant, SLC26A7.2, was reported.   The last 11 residues of SLC26A7 are replaced by a 
novel 18-amino acid sequence in the 663-amino-acid SLC26A7.2 isoform (Vincourt et al. 2002).  
 
Table 3. The exon structure and conservation within the SLC26 family 
 1 2 3 4 5 6 7 8 9 10 11 
SLC26A3 107 219 140 111 188 165 153 83 148 114 78 
SLC26A4 221 167 140 111 185 165 153 83 148 114 78 
SLC26A6  159 140 111 152 165 153 83 148 114 78 
SLC26A7  96 306 111 173 165 153 83 148 114 78 
SLC26A8 110 190 140 116 162 165 150 83 148 114 78 
SLC26A9 96 142 140 111 176 165 153 83 148 114 78 
 
 12 13 14 15 16 17 18 19 20 21 
SLC26A3 96 107 70 93 96 234 55 146 67 21 
SLC26A4 96 107 70 93 96 231 55 146 84 23 
SLC26A6 96 107 70 93 118 93 177 55 137 15 
SLC26A7 96 107 67 138 49 101 55 104 36  
SLC26A8 96 107 70 93 132 369 55 185 441  
SLC26A9 96 107 70 93 114 282 55 146 72 48 
 
 
The SLC26A7 protein shows ~50% similarity to SLC26A2 and A3 proteins (BLASTP E-value ~1e-
80). Two putative N-glycosylation sites at Asn125 and Asn131 were identified. Furthermore, the 
SLC26A7 protein sequence has ST and STAS domains and the C-terminus (SEV) comprises the 
consensus PDZ interacting motif (Table 4).  PSIpred program predicted a 12-transmembrane 
structure with intracellular N- and C-terminal domains. 
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SLC26A8. The complete sequence of SLC26A8 was constructed from two different genomic 
clones in chromosome 6.  In addition, the 5´and 3´-regions were expanded and verified by RT-PCR.  
The complete cDNA sequence (GenBank Accession No. AF331522) includes an open reading 
frame of 1971 bp encoding a 970 amino acid protein.  The SLC26A8 gene contains 20 exons and 
spans about 80 kb of genomic sequence. The putative ATG translation start site is within the Kozak 
consensus sequence and a 361-bp 3' untranslated region precedes the consensus polyadenylation 
signal AATAAA. A number of exons show conservation of the size, although there are more 
variations when compared with the other family members.   
 
The SLC26A8 protein shows the best sequence similarity to SLC26A3 and SLC26A6 (BLASTP E-
value= 2e-78 and 1e-73, respectively). However, the SLC26A8 protein possesses 200-300 amino 
acids more than the other members and SLC26A8-specific extra sequences were found between 
amino acids 600-652 and C-terminal regions. Furthermore, comparison of the SLC26A8 protein 
with the other family members reveals several unconserved residues (Fig. 8). Altogether eight 
putative N-glycosylation sites were found along the protein at Asn52, Asn192, Asn277, Asn384, Asn595, 
Asn651, Asn687 and Asn688. The eleven-transmembrane structure of the SLC26A8 protein with 
intracellular N-terminal domain and extracellular C-terminal domain was predicted by TMHMM 
program, whereas PSIpred failed to predict any structures for the protein. ProfileScan analysis of 
the SLC26A8 protein sequence found ST (aa 212-521) and STAS (aa 544-791) domains (Table 4).  
 
 
Table 4. Analysis of the common conserved domains of the SLC26 family by ProfileScan.  
Domain Profile A1 A2 A3 A4 A5 A6 A7 A8 A9 
ST FAMILY PF00916 36.5 39.5 37.8 33.5 33.5 34.9 29 27.1 29.4 
STAS PS50801 18.4 18.1 14.7 18.8 16.7 10.9 17.6 11.6 17.4 
ST SIGNAT PS01130 1.0 1.0 1.0 1.0 - - - - - 
NLS BP PS50079 - - 3.0 - 3.0 - - 3.0 - 
XAN UR PERM PF00860 - - 8.5 8.6 - 8.5 9.2 9.5 - 
PROK LIPOPRO PS00013 1.0 - 1.0 1.0 1.0 - 1.0 1.0 1.0 
PDZ T/S-X-ф - X X - - X X - X 
ST FAMILY, sulfate transporter family domain; STAS, sulfate transporters and antisigmafactor antagonists; 
ST SIGNATURE, sulfate transporter signature; NLS BP, nuclear localization bipartite signal; XAN UR 
PERM, xanthine/uracil permeases family; PROK LIPOPRO, prokaryotic membrane lipoprotein lipid 
attachment site; PDZ, PSD-95/Disc-large/ZO-1 domain; ф is a hydrophobic amino acid 
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SLC26A9.  A homology search with the sulfate transport signature motif of the human SLC26A3 
protein against NCBI´s htgs database with TBLASTN algorithm resulted in an interesting match (E-
value=0.001) in the genomic PAC clone RP11-370I5 (GenBank accession AL360009) in 
chromosome 1.  Subsequent cloning efforts revealed a cDNA sequence including an open reading 
frame of 2373 bp encoding a 791 amino acid protein designated SLC26A9 (GenBank Accession 
AF331525).   
 
The total length of the gene spans about 25 kb of the genomic sequence. The open reading frame is 
distributed across 21 exons ranging in size from 55 to 282 bp. Exon-intron boundaries obey the 
general AG-GT rule and 14 of 20 exons are exactly of the same size as those of the SLC26A3 and 
SLC26A4 genes. A 115-bp untranslated region including the first exon precedes that methionine 
and a putative TATA box lies 25 bp upstream from the first exon. A 2308-bp 3' untranslated region 
precedes the consensus polyadenylation signal AATAAA.  Futhermore, PCR analysis proposed two 
alternatively spliced variants for SLC26A9.  Sequencing revealed that the second or fourth exon of 
SLC26A9 is spliced out, which results in the truncation of the first 89 N-terminal amino acids or the 
deletion of amino acids 90 to 126 (37 residues) of the protein, respectively. 
 
The SLC26A9 protein is highly conserved with the known family member (Fig. 8). SLC26A9 has 
two putative N-glycosylation sites at Asn153 and Asn156. ProfileScan analysis of the SLC26A9 
protein sequence revealed ST (aa 187-497) and STAS (aa 520-733) domains (Table 4).  The C-
terminus of the SLC26A9 protein (TAL) comprises the consensus PDZ-protein interacting motif 
(Table 4).  The nine-transmembrane structure of the protein with intracellular N-terminal and 
extracellular C-terminal domains was suggested by the PSIpred and TMHMM programs. 
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  A5    1 -------------MDHAEENEIPVATQKYHVER---------------PIFSHPVLQERLHVKDKVSESIGDKLKQA-----FTCTPKKIRNIIYMFLPITKWLPAYKFK 
A6    1 ---------------------MDLRRRDYHMER---------------PLLNQEHLEELGRWG---SAPRTHQWRTW-----LQCSRARAYALLLQHLPVLVWLPRYPVR 
A9    1 ---------------------MSQPRPRYVVDR---------------AAYSLTLFDDEFEKKDR-TYPVGEKLRNA-----FRCSSAKIKAVVFGLLPVLSWLPKYKIK 
A1    1 --------MDESPEPLQQGRGPVP-------------------------------VRRQRPAPRGLREMLKARLWCS-----CSCSVLCVRALVQDLLPATRWLRQYRPR 
A2    1 MSSESKEQHNVSPRDSAEGNDSYPSGIHLELQRESSTDFKQFETNDQCRPYHRILIERQEKSDTNFKEFVIKKLQKN-----CQCSPAKAKNMILGFLPVLQWLPKYDLK 
A3    1 ---------MIEPFGN-----------QYIVAR---------------PVYSTNAFEENHKKTGRHHKTFLDHLKVC-----CSCSPQKAKRIVLSLFPIASWLPAYRLK 
A4    1 ---------MAAPGGRSEPPQLPEYSCSYMVSR---------------PVYSELAFQQQHERRLQERKTLRESLAKC-----CSCSRKRAFGVLKTLVPILEWLPKYRVK 
A7    1 -------------------------------------------------------------MTGAKRKKKSMLWSKM-----HTPQCEDIIQWCRRRLPILDWAPHYNLK 
A8    1 ------MAQLERSAISGFSSKSRRNSFAYDVKR---------------EVYNEETFQQEHKRKASSSGNMNINITTFRHHVQCRCSWHRFLRCVLTIFPFLEWMCMYRLK 
 
A5   78 EYVLGDLVSGISTGVLQLPQGLAFAMLAA--VPPVFGLYSSFYPVIMYCFFGTSRHISIGPFAVISLMIGG---------VAVRLVPDD------IVIPGGVNATNGTEA 
A6   67 DWLLGDLLSGLSVAIMQLPQGLAYALLAG--LPPVFGLYSSFYPVFIYFLFGTSRHISVGTFAVMSVMVGS---------VTESLAPQA------LNDS-MINET----A 
A9   69 DYIIPDLLGGLSGGSIQVPQGMAFALLAN--LPAVNGLYSSFFPLLTYFFLGGVHQMVPGTFAVISILVGN---------ICLQLAPESK---FQVFNNATNESYVDTAA 
A1   67 EYLAGDVMSGLVIGIILVPQAIAYSLLAG--LQPIYSLYTSFFANLIYFLMGTSRHVSVGIFSLLCLMVGQVVDRELQLAGFD--PSQDGLQPGANSSTLNGSAAMLDCG 
A2  106 KNILGDVMSGLIVGILLVPQSIAYSLLAG--QEPVYGLYTSFFASIIYFLLGTSRHISVGIFGVLCLMIGETVDRELQKAGYDNAHSAPSLGMVSNGSTLLNHTSDRICD 
A3   71 EWLLSDIVSGISTGIVAVLQGLAFALLVD--IPPVYGLYASFFPAIIYLFFGTSRHISVGPFPILSMMVGLAVS-----GAVSKAVPDRNATTLGLPNNSNNSSLLD--- 
A4   82 EWLLSDVISGVSTGLVATLQGMAYALLAA--VPVGYGLYSAFFPILTYFIFGTSRHISVGPFPVVSLMVG---------SVVLSMAPDEHFLVSSSNGTVLNTTMIDTAA 
A7   45 ENLLPDTVSGIMLAVQQVTQGLAFAVLSS--VHPVFGLYGSLFPAIIYAIFGMGHHVATGTFALTSLISAN---------AVERIVPQN----MQNLTTQSNTSVLGLSD 
A8   90 DWLLGDLLAGISVGLVQVPQGLTLSLLARQLIPPLNIAYAAFCSSVIYVIFGSCHQMSIGSFFLVSALLIN----------VLKVSPFNNGQLVMGSFVKNEFSAPSYLM 
 
A5  171 RDALRVKVAMSVTLLSGIIQFCLGVCRFGFVAIYLTEPLVRGFTTAAAVHVFTSMLKYLFGVKTKRYSGIFSVVYSTVAVLQNVKNLNVCSLGVGLMVFGLLLGGKEFNE 
A6  155 RDAARVQVASTLSVLVGLFQVGLGLIHFGFVVTYLSEPLVRGYTTAAAVQVFVSQLKYVFGLHLSSHSGPLSLIY-VLEVCWKLPQSKVGTVVTAAVAGVVLVVVKLLND 
A9  165 MEAERLHVSATLACLTAIIQMGLGFMQFGFVAIYLSESFIRGFMTAAGLQILISVLKYIFGLTIPSYTGPGSIVFTFIDICKNLPHTNIASLIFALISGAFLVLVKELNA 
A1  173 RDCYAIRVATALTLMTGLYQVLMGVLRLGFVSAYLSQPLLDGFAMGASVTILTSQLKHLLGVRIPRHQGPGMVVLTWLSLLRGAGQANVCDVVTSTVCLAVLLAAKELSD 
A2  214 KSCYAIMVGSTVTFIAGVYQVAMGFFQVGFVSVYLSDALLSGFVTGASFTILTSQAKYLLGLNLPRTNGVGSLITTWIHVFRNIHKTNLCDLITSLLCLLVLLPTKELNE 
A3  171 DERVRVAAAASVTVLSGIIQLAFGILRIGFVVIYLSESLISGFTTAAAVHVLVSQLKFIFQLTVPSHTDPVSIFKVLYSVFSQIEKTNIADLVTALIVLLVVSIVKEINQ 
A4  181 RDTARVLIASALTLLVGIIQLIFGGLQIGFIVRYLADPLVGGFTTAAAFQVLVSQLKIVLNVSTKNYNGVLSIIYTLVEIFQNIGDTNLADFTAGLLTIVVCMAVKELND 
A7  140 FEMQRIHVAAAVSFLGGVIQVAMFVLQLGSATFVVTEPVISAMTTGAATHVVTSQVKYLLGMKMPYISGPLGFFYIYAYVFENIKSVRLEALLLSLLSIVVLVLVKELNE 
A8  190 GYNKSLSVVATTTFLTGIIQLIMGVLGLGFIATYLPESAMSAYLAAVALHIMLSQLTFIFGIMISFHAGPISFFYDIINYCVALPKANSTSILVFLTVVVALRINKCIRI 
 
A5  281 RFKEKLPAPIPLEFFAVVMGTGISAGFNLHESYSVDVVGTLPLGLLPPANPDTSLFHLVYVDAIAIAIVGFSVTISMAKTLANKHGYQVDGNQELIALGICNSIGSLFQT 
A6  264 KLQQQLPMPIPGELLTLIGATGISYGMGLKHRFEVDVVGNIPAGLVPPVAPNTQLFSKLVGSAFTIAVVGFAIAISLGKIFALRHGYRVDSNQELVALGLSNLIGGIFQC 
A9  275 RYMHKIRFPIPTEMIVVVVATAISGGCKMPKKYHMQIVGEIQRGFPTPVSPVVSQWKDMIGTAFSLAIVSYVINLAMGRTLANKHGYDVDSNQEMIALGCSNFFGSFFKI 
A1  283 RYRHRLRVPLPTELLVIVVATLVSHFGQLHKRFGSSVAGDIPTGFMPPQVPEPRLMQRVALDAVALALVAAAFSISLAEMFARSHGYSVRANQELLAVGCCNVLPAFLHC 
A2  324 HFKSKLKAPIPIELVVVVAATLASHFGKLHENYNSSIAGHIPTGFMPPKVPEWNLIPSVAVDAIAISIIGFAITVSLSEMFAKKHGYTVKANQEMYAIGFCNIIPSFFHC 
A3  281 RFKDKLPVPIPIEFIMTVIAAGVSYGCDFKNRFKVAVVGDMNPGFQPPITPDVETFQNTVGDCFGIAMVAFAVAFSVASVYSLKYDYPLDGNQELIALGLGNIVCGVFRG 
A4  291 RFRHKIPVPIPIEVIVTIIATAISYGANLEKNYNAGIVKSIPRGFLPPELPPVSLFSEMLAASFSIAVVAYAIAVSVGKVYATKYDYTIDGNQEFIAFGISNIFSGFFSC 
A7  250 QFKRKIKVVLPVDLVLIIAASFACYCTNMENTYGLEVVGHIPQGIPSPRAPPMNILSAVITEAFGVALVGYVASLALAQGSAKKFKYSIDDNQEFLAHGLSNIVSSFFFC 
A8  300 SFN-QYPIEFPMELFLIIGFTVIANKISMATETSQTLIDMIPYSFLLPVTPDFSLLPKIILQAFSLSLVSSFLLIFLGKKIASLHNYSVNSNQDLIAIGLCNVVSSFFRS 
 
A5  391 FSISCSLSRSLVQEGTGGKTQLAGCLASLMILLVILATGFLFESLPQAVLSAIVIVNLKGMFMQFSDLPFFWRTSKIELTIWLTTFVSSLFLGLDYGLITAVIIALLTVI 
A6  374 FPVSCSMSRSLVQESTGGNSQVAGAISSLFILLIIVKLGELFHDLPKAVLAAIIIVNLKGMLRQLSDMRSLWKANRADLLIWLVTFTATILLNLDLGLVVAVIFSLLLVV 
A9  385 HVICCALSVTLAVDGAGGKSQVASLCVSLVVMITMLVLGIYLYPLPKSVLGALIAVNLKNSLKQLTDPYYLWRKSKLDCCIWVVSFLSSFFLSLPYGVAVGVAFSVLVVV 
A1  393 FATSAALAKSLVKTATGCRTQLSSVVSATVVLLVLLALAPLFHDLQRSVLACVIVVSLRGALRKVWGFPRLWRMSPADALVWAGTAATCMLVSTEAGLLAGVILSLLSLA 
A2  434 FTTSAALAKTLVKESTGCHTQLSGVVTALVLLLVLLVIAPLFYSLQKSVLGVITIVNLRGALRKFRDLPKMWSISRMDTVIWFVTMLSSALLSTEIGLLVGVCFSIFCVI 
A3  391 FAGSTALSRSAVQESTGGKTQIAGLIGAIIVLIVVLAIGFLLAPLQKSVLAALALGNLKGMLMQFAEIGRLWRKDKYDCLIWIMTFIFTIVLGLGLGLAASVAFQLLTIV 
A4  401 FVATTALSRTAVQESTGGKTQVAGIISAAIVMIAILALGKLLEPLQKSVLAAVVIANLKGMFMQLCDIPRLWRQNKIDAVIWVFTCIVSIILGLDLGLLAGLIFGLLTVV 
A7  360 IPSAAAMGRTAGLYSTGAKTQVACLISCIFVLIVIYAIGPLLYWLPMCVLASIIVVGLKGMLIQFRDLKKYWNVDKIDWGIWVSTYVFTICFAANVGLLFGVVCTIAIVI 
A8  409 CVFTGAIARTIIQDKSGGRQQFASLVGAGVMLLLMVKMGHFFYTLPNAVLAGIILSNVIPYLETISNLPSLWRQDQYDCALWMMTFSSSIFLGLDIGLIISVVSAFFITT 
 
A5  501 YRTQSPSYKVLGQLPDTDVYIDIDAYEEVKEIPGIKIFQINAPIYYANSDLYSNALKRKTGVNPALIMGARRKAMR---------------------------------- 
A6  484 VRTQMPHYSVLGQVPDTDIYRDVAEYSEAKEVRGVKVFRSSATVYFANAEFYSDALKQRCGVDVDFLISQKKKLLKKQEQL----------------------------- 
A9  495 FQTQFRNGYALAQVMDTDIYVNPKTYNRAQDIQGIKIITYCSPLYFANSEIFRQKVIAKTGMDPQKVLLAKQKYLKKQEKR----------------------------- 
A1  503 GRTQRPRTALLARIGDTAFYEDATEFEGLVPEPGVRVFRFGGPLYYANKDFFLQSLYSLTGLDAGCMAARRKEGGSETG------------------------------- 
A2  544 LRTQKPKSSLLGLVEESEVFESVSAYKNLQTKPGIKIFRFVAPLYYINKECFKSALYKQTVNPILIKVAWKK--AAKRK------------------------------- 
A3  501 FRTQFPKCSTLANIGRTNIYKNKKDYYDMYEPEGVKIFRCPSPIYFANIGFFRRKLIDAVGFSPLRILRKRNKALRKIR------------------------------- 
A4  511 LRVQFPSWNGLGSIPSTDIYKSTKNYKNIEEPQGVKILRFSSPIFYGNVDGFKKCIKSTVGFDAIRVYNKRLKALRKIQ------------------------------- 
A7  470 G--RFPRAMTVSIKNMKEMEFKVKTEMDSETLQQVKIISINNPLVFLNAKKFYTDLMNMIQKE-----NACNQPLDDIS------------------------------- 
A8  519 VRSHRAKILLLGQIPNTNIYRSINDYREIITIPGVKIFQCCSSITFVNVYYLKHKLLKEVDMVKVPLKEEEIFSLFNSSDTNLQGGKICRCFCNCDDLEPLPRILYTERF 
 
A5  577 --------------KYAKEVGNANIANAAVVKVDGEVDGENATKPEEED-------------DEVKYPPIVI-----KTTFPEELQRFMPQTENVHTIILDFTQVNFIDS 
A6  565 --------KLKQLQKEEKLRKQAASPKGASVSINVNTSLEDMRSNNVEDCKMMQVSSGDKMEDATANGQEDS-----KAPDGSTLKALGLPQPDFHSLILDLGALSFVDT 
A9  576 --------RMRPTQQRRSLFMKTKTVSLQELQQDFENAPPTDPNNNQTPANGTSVSYITFSPDSSSPAQSEPPASAEAPGEPSDMLASVPPFVTFHTLILDMSGVSFVDL 
A1  582 --------------VGEGGPAQGEDLGPVSTRAALVPAAAG-----------------------------------------------------FHTVVIDCAPLLFLDA 
A2  621 --------------IKEKVVTLGGIQDEMS--VQLSHDPLE-----------------------------------------------------LHTIVIDCSAIQFLDT 
A3  580 --------------KLQKQGLLQVTPKGFICTVDTIKDSDEELDNNQIEVLDQPINTTDLPFHIDWNDDLPL--------------NIEVPKISLHSLILDFSAVSFLDV 
A4  590 --------------KLIKSGQLRATKNGIISDAVSTNNAFE-PDEDIEDLEELDIPTKEIEIQVDWNSELPV--------------KVNVPKVPIHSLVLDCGAISFLDV 
A7  542 --------------KCEQNTLLNSLSNGNCNEEASQSCPNE-----------------------------------------------------KCYLILDCSGFTFFDY 
A8  629 ENKLDPEASSINLIHCSHFESMNTSQTASEDQVPYTVSSVSQKNQGQQYEEVEEVWLPNNSSRNSSPGLPDVAES--QGRRSLIPYSDASLLPSVHTIILDFSMVHYVDS 
 
A5  655 VGVKTLAVMVKEYGDVGIYVYLAGCSPQVVNDLTRN-RFFEN---PALKELLFHSIHDAVLGSHVREAMAEQEASAPPPQDDMEPNATPTTPEA---------------- 
A6  662 VCLKSLKNIFHDFREIEVEVYMAACHSPVVSQLEAG-HFFDA---SITKKHLFASVHDAVT----------FALQHPRPVPDSPVSVTRL-------------------- 
A9  678 MGIKALAKLSSTYGKIGVKVFLVNIHAQVYNDISHGGVFEDG---SLECKHVFPSIHDAVLFAQANARDVTPGHNFQGAPGDAELSLYDSEEDIRSYWDLEQEMFGSMFH 
A1  625 AGVSTLQDLRRDYGALGISLLLACCSPPVRDILSRGGFLGEGPGDTAEEEQLFLSVHDAVQTARARHR------------ELEATDAHL--------------------- 
A2  662 AGIHTLKEVRRDYEAIGIQVLLAQCNPTVRDSLTNGEYCKK-----EEENLLFYSVYEAMAFAEVSKN------------QKGVCVPNGLSLSSD--------------- 
A3  662 SSVRGLKSILQEFIRIKVDVYIVGTDDDFIEKLNRYEFFDG----EVKSSIFFLTIHDAVLHILMKKDYSTS------KFNPSQEKDGKIDFTINTNGGLRNRVYEVPVE 
A4  671 VGVRSLRVIVKEFQRIDVNVYFASLQDYVIEKLEQCGFFDD----NIRKDTFFLTVHDAILYLQNQVKSQEGQGSILETITLIQDCKDTLELIETELTEEELDVQDEAMR 
A7  585 SGVSMLVEVYMDCKGRSVDVLLAHCTASLIKAMTYYGNLD------SEKPIFFESVSAAISHIHSNKN-----------LSKLSDHSEV--------------------- 
A8  737 RGLVVLRQICNAFQNANILILIAGCHSSIVRAFERNDFFDAG----ITKTQLFLSVHDAVLFALSRKVIGSSELSIDESETVIRETYSETDKNDNSRYKMSSSFLGSQKN 
 
A5      -------------------------------------------------------------------------------------------------------------- 
A6      -------------------------------------------------------------------------------------------------------------- 
A9  785 AETLTAL------------------------------------------------------------------------------------------------------- 
A1      -------------------------------------------------------------------------------------------------------------- 
A2      -------------------------------------------------------------------------------------------------------------- 
A3  762 TKF----------------------------------------------------------------------------------------------------------- 
A4  777 TLAS---------------------------------------------------------------------------------------------------------- 
A7      -------------------------------------------------------------------------------------------------------------- 
A8  843 VSPGFIKIQQPVEEESELDLELESEQEAGLGLDLDLDRELEPEMEPKAETETKTQTEMEPQPETEPEMEPNPKSRPRAHTFPQQRYWPMYHPSMASTQSQTQTRTWSVER 
 
A8  953 RRHPMDSYSPEGNSNEDV 
 
Figure 8. Multiple alignment of the SLC26 family members. 
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5.3. Tissue-specific expression patterns of SLC26A6-A9 
SLC26A6. The 2748 bp full-length cDNA of SLC26A6a corresponds well with the observed size 
(~3 kb) in northern analysis, and it revealed a specific tissue distribution, with most abundant 
expression in kidney, pancreas, placenta and skeletal muscle. PCR analysis demonstrated that 
SLC26A6a is widely expressed, but at highest level in kidney and pancreas. PCR analysis 
suggested also the existence of alternatively spliced forms of the gene, in accordance with the 
northern analysis.   
 
To verify and refine the expression results, we analysed two human pancreatic duct cell lines, 
Capan-1 and Capan-2, and the human embryonal kidney (HEK) cell line 293 by RT-PCR. All three 
cell lines expressed SLC26A6. Characterization by in situ hybridization and immunohistochemistry 
detected SLC26A6 at apical and basolateral surface of tubular walls in kidney and in the brush 
border of pancreatic duct, suggesting a functional role for SLC26A6 as a pancreatic and/or renal 
anion exchanger. 
 
Tissue distribution of the SLC26A6a, SLC26A6c and SLC26A6d variants were compared by PCR 
amplification of multiple tissue cDNA panels. Specific primers were designed to amplify both 
SLC26A6a and A6c genes at the same reaction. SLC26A6a was detected in all tissues, while 
SLC26A6c showed a more restricted expression pattern. The expression of SLC26A6d gene was 
observed in many tissues, but mainly in the kidney and pancreas. All isoforms were expressed in the 
pancreatic ductal cell line, Capan-1. These results suggested tissue-specific functions for different 
SLC26A6 variants. 
 
The exact topologies of the SLC26 anion exchangers are uncertain.  In order to determine the 
location of the N- and C-termini of the SLC26A6 variants relative to plasma membrane, anti-
SLC26A6 antibodies specific to the N- and C-terminal tails were used in permeabilized and 
nonpermeabilized SLC26A6a, A6c and A6d-transfected cells. Transiently transfected COS-1 cells 
expressed all isoforms as shown with permeabilized cells, while untransfected cells remained 
negative. However, no labelling was observed either with N-terminal or C-terminal antibodies in 
non-permeabilized cells with SLC26A6a and A6c isoforms, demonstrating that both the N- and C-
termini of the proteins are located intracellularly. Similarly, the N-terminus of SLC26A6d was 
located intracellularly.  In the lack of a specific antibody the altered C-terminus of SLC26A6d 
compared to SLC26A6a could not be localized.  Similar results were observed also with an 
alternative permeabilization procedure with saponin (unpublished results).  
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The specificity of the antibodies was confirmed by western blotting, which showed that both N- and 
C-terminal antibodies bind specifically to the SLC26A6a protein (about 85 kDa) in transfected cells 
as compared with the untransfected cells. Similar results were observed also with in vitro translated 
SLC26A6a protein. The membranes stained with preimmune sera remained negative.  Altogether, 
our results support models with an even number of transmembrane helices, consistent with the 
predicted topology of SLC26A6a, SLC26A6c and SLC26A6d proteins.   Thus, the topologies of the 
SLC26A6 variants resemble the model suggested for SLC26A5, which is the closest homolog of 
SLC26A6.  It follows from these results that the N- and C- termini are possible sites for interaction 
with cytoplasmic proteins. 
 
SLC26A7. The tissue distribution of the SLC26A7 gene was determined by northern hybridization 
and PCR using Clontech´s multiple tissue cDNA panels with 16 different tissues. The 5250 bp full-
length cDNA of SLC26A7 corresponds well with the observed size (~5 kb) in northern analysis, 
and it revealed a specific tissue distribution, with most abundant expression in the kidney. A weaker 
~3.0 kb transcript was also observed and it might be derived from an alternative polyadenylation of 
the gene. The long 3´UTR of the SLC26A7 gene contains a number of consensus AAUAAA or 
AUUAAA sequences that may serve as alternative polyadenylation signals in a reasonable 
agreement with the size of the less abundant  ~3.0 kb transcript. PCR analysis showed also most 
abundant expression in kidney, placenta and testis supporting the northern analysis. Analysis of 
SLC26A7 expression by immunohistochemistry localized it to distal segments of nephrons in the 
kidney, while the proximal tubules remained negative.  
 
SLC26A8. Both northern and PCR analyses revealed a testis-specific distribution for SLC26A8. 
The 3371 bp cDNA of SLC26A8 corresponded with the observed size (~3.5 kb) in northern 
analysis. Cell-specific localization of SLC26A8 using in situ hybridization and 
immunohistochemistry suggest that the expression of SLC26A8 is restricted to the meiotic phase of 
the germ cells in the human testis. The SLC26A8 antisense cRNA probe revealed abundant 
expression in the seminiferous tubules and mRNA was concentrated on the luminal side of the 
tubuli harboring the spermatocytes and the spermatids, while the peripheral side of the tubuli, 
containing the spermatogonia, appeared negative. Consistently, immunohistochemical stainings 
localized SLC26A8 protein exclusively to developing spermatocytes and spermatids.   
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SLC26A9. PCR analysis suggested that SLC26A9 is expressed predominantly in the lung, although 
some expression was found also in the pancreas, prostate and kidney. The lung-specific expression 
of SLC26A9 was confirmed by northern blotting. The 4815 bp cDNA of SLC26A9 corresponded 
with the observed size (~4.8 kb) in northern analysis.  SLC26A9 expression was found also in two 
human lung-derived carcinoma cell lines, NCI-H358 and A549, from bronchoalveolus and alveolus, 
respectively. Furthermore, SLC26A9 was detected in the bronchiolar and alveolar epithelium of 
lung by immunohistochemistry.   
 
5.4. SLC26A6-A9 function as anion exchangers and may interact with PDZ proteins 
The high homology of the SLC26A6-A9 proteins to the known family members suggested a related 
transport functions. Functional characterization of the proteins was performed in Xenopus laevis 
oocytes. In vitro transcribed cRNAs were injected into oocytes and transport function was measured 
by 35S-sulfate, 36Cl-chloride and 14C-oxalate uptakes. Expression of SLC26A6 isoforms revealed 
induction of chloride and sulfate transport compared to water controls. Furthermore, the sulfate 
uptake was inhibited by anion exchanger inhibitor, DIDS, and also by HCO3-, suggesting that 
bicarbonate competes the same binding site of the proteins with sulfate and would be therefore a 
substrate as well.  We found also that SLC26A6a accepts oxalate as a substrate.  
 
Similarly, the expression of SLC26A7-A9 proteins led to the induction of chloride, sulfate and 
oxalate transport above water-injected oocytes. Furthermore, the SLC26A9-mediated sulfate 
transport was inhibited by DIDS and thiosulfate, but not by oxalate or glucose. Similar inhibition of 
SLC26A8 activity by DIDS was observed previously (Toure et al. 2001).  During this study, the 
characterization of a novel sulfate transporter, Tat1 (testis anion transporter 1), was published 
(Toure et al. 2001). Our results identify Tat1 and SLC26A8 as the same gene and confirm 
observation regarding its expression and function.   Altogether, these results demonstrate that 
SLC26A6-A9 proteins function as novel anion exchangers. 
 
Recent studies have demonstrated that PDZ domain proteins play an essential role in the assembly 
of multiprotein complexes involved in determining cell polarity, plasma membrane targeting and 
regulation of membrane proteins (Fanning et al 1998).  Since the ultimate C-terminus of SLC26A6a 
and SLC26A6c contain a consensus PDZ-interaction motif (TRL), it prompted us to test its putative 
binding to different PDZ domains of the E3KARP and NHERF proteins in vitro. The intact C-
terminus of SLC26A6a and A6c, but not the SLC26A6adel mutation missing the PDZ interaction 
motif, bound to full length NHERF and E3KARP. This result demonstrated the functionality and 
 55
     
specificity of the C-terminal TRL motif of SLC26A6a and SLC26A6c for interaction with NHERF 
and E3KARP. In order to test whether this interaction indeed occurred through the PDZ domains of 
these proteins, the PDZ domains and the C-terminus of NHERF and E3KARP were individually 
tested for binding. SLC26A6 was found to bind to both PDZ domains but not to the C-terminus of 
NHERF and E3KARP.  Interestingly, many other SLC26 family members possess also the 
consensus PDZ interaction motif in the C-termini, suggesting that the PDZ interaction pathways 
play an important role in the regulation of this group of transporters.  
 
5.5. Upregulation of CFTR but not SLC26A3 and SLC9A3 expression in ulcerative colitis 
In normal colonic mucosa, the absorption of salt is driven by active transporters, followed by 
passive movements of water. Much of the absorption of NaCl is mediated by electroneutral pH-
coupled Na+/H+ and Cl-/HCO-3 exchangers (Knickelbein et al. 1985). SLC26A3 most likely 
functions as a major Cl-/HCO3- exchanger in the colon, and much of the intestinal Na+/H+ 
exchanger activity is mediated by SLC9A3 (known also as NHE3) (Kere et al. 1999; Gawenis et al. 
2002). The latter notion is supported by the targeted disruption of the SLC9A3 gene, which results 
in sodium diarrhea and acidosis (Schultheis et al. 1998). The SLC9A3 gene belongs to the sodium 
proton exchanger (NHE) family, SLC9, in which seven different isoforms have been identified to 
date.  Cystic fibrosis transmembrane regulator (CFTR), the gene for one of the most common 
inherited diseases worldwide, cystic fibrosis, acts as the major mediator of cAMP- and Ca2+-
activated Cl- secretion in the colonic epithelium (Mall et al. 1998).   
 
In inflamed colonic mucosa, the equilibrium between absorptive and secretory functions for 
electrolyte and water transport is disturbed.   Therefore, we compared the expression of three major 
mediators of the intestinal salt transport, CFTR, SLC26A3 and SLC9A3 between healthy and 
inflamed colonic mucosa to understand the pathophysiology of diarrhoea in inflammatory bowel 
disease. Real-time quantitative RT-PCR, immunohistochemistry and Western blotting were applied 
to measure the expression levels in peroperative samples from normal (n=12) and UC patients´ 
colon (n=30).  Expression levels were normalised to S18 transcripts in RT-PCR. The activity of 
inflammation was determined by histological evaluation of the peroperative colonic samples graded 
in three subgroups (mild, moderate and severe).  
 
CFTR. In inflamed colonic mucosa, the CFTR mRNA expression was increased 2.5-fold compared 
to non-inflamed samples (p=0.0002, Mann-Whitney U-test), when all subgroups were analysed 
together. Characterization of the three subgroups of inflammation demonstrated upregulated 
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expression of the CFTR mRNA in all stages of inflamed tissues: about 5-fold in mildly inflamed 
samples (p<0.001), about 2-fold in moderate and ~1.5-fold in severely inflamed colon mucosa when 
compared to normal.   
 
To assess putative alterations in the CFTR protein expression in response to inflammation, a set of  
inflammatory samples were studied using immunohistochemistry with a monoclonal CFTR 
antibody and compared to the normal control. The CFTR-specific immunoreactivity was detected 
only at the apical edge of the cryptal epithelial cells corresponding well with the functional CFTR 
protein at the apical membrane. All ulcerative colitis samples demonstrated the expression of the 
CFTR protein similar to the normal colon epithelium. Interestingly, some inflammatory samples 
demonstrated also cytoplasmic expression of the CFTR protein that was not detected in normal 
control samples. 
 
SLC26A3. In contrast to CFTR, the expression levels of the SLC26A3 mRNA was not different 
between normal and inflamed mucosa, when all subgroups were analysed together (p=0.11) In 
different subgroups, an increased expression of SLC26A3 in mild inflammation (~1.5-fold) was 
followed by reduction in moderate (~2-fold) and severe inflammation (~3-fold). Expression of 
SLC26A3 was significantly changed  (p<0.05) only in the severely inflamed tissue when compared 
to normal.  
 
To study whether the levels of the SLC26A3 mRNA correlate with the protein expression levels, 
Western immunoblotting was performed using differently inflamed colon tissues. Antibody against 
the N-terminal part of the SLC26A3 protein detected a specific band of 85 kDa in all samples, and 
antibody against the C-terminal tail of the SLC26A3 peptide detected two protein bands at about 85 
and 75 kDa.  The intensities of the bands in mildly and severely inflamed samples appeared 
identical, suggesting that the expression of SLC26A3 remains unchanged even in severely inflamed 
colon tissue.  These results were statistically verified by measuring a total of 30 immunoreactive 
bands from 10 patients by densitometric scanning of the autoradiographs. There was no significant 
difference (p=0.8) in mean protein expression in normal versus inflamed tissues. Characterization 
of the subgroups demonstrated also that SLC26A3 expression remains unchanged in all stages of 
inflamed tissues.  However, the amino terminal part of the SLC26A3 protein might undergo 
posttranslational cleavage, because the N-terminal antibody detected only the larger 85 kDa band 
corresponding with the predicted molecular weight of the SLC26A3 protein.  This observation is 
supported by the previous studies (Byeon et al. 1996).   
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SLC9A3. Similar to SLC26A3, the expression level of the SLC9A3 mRNA remained unchanged 
between normal and inflamed mucosa, when all subgroups were analysed together (p=0.5). In 
different subgroup, the initial upregulation in both mild (~3-fold) and moderate (~1.5-fold) was 
followed in severe inflammation by return to the same level as in non-inflamed samples. 
Statistically significant difference was seen only between mild and severe groups.  These results are 
consistent with the previous studies demonstrating unchanged protein expression of SLC9A3 in an 
UC patient (Yang et al. 1998). 
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6. DISCUSSION 
 
6.1. The SLC26 family is complemented with several new homologous members 
The systematic characterization of gene families using genome sequences provides a rich source for 
expanding our physiological understanding of body functions. A second distinct family of anion 
exchangers, in addition to the classical SLC4 family, has recently been delineated. Particular 
interest in the SLC26 family is stimulated by the fact that the first three human genes, SLC26A2, 
SLC26A3 and SLC26A4, have been recognized as the disease genes mutated in diastrophic 
dysplasia, congenital chloride diarrhoea and Pendred syndrome, respectively. A growing interest is 
further feeded by the existence of new tissue-specific members, which might associate with diseases 
as well (Everett and Green 1999; Kere et al. 1999).  By a genome-driven approach, we have 
identified seven novel loci with distinct tissue expression patterns. Currently, the expanded human 
SLC26 family includes at least eleven tissue-specific members, termed SLC26A1-A11 (Table 5).   
 
We cloned SLC26A1, which likely represents the human ortholog of the rat and murine slc26a1 
genes (sat-1) because of its high homology and expression pattern.  Its transport function has not 
been determined yet, but it likely resembles that of rat and murine slc26a1 (Bissig et al. 1994). 
SLC26A2 to A4 have been shown to transport with different specificities the chloride, sulfate, 
iodide, bicarbonate, oxalate and hydroxyl anions, and they play central roles in the etiology of 
phenotypically very different recessive diseases (Hästbacka et al. 1994; Silberg et al. 1995; Satoh et 
al. 1998; Moseley et al. 1999; Scott et al. 1999; Scott and Karniski 2000).  
 
During this study, the SLC26A5 gene (Pres), encoding 744-amino-acid protein, Prestin, was also 
cloned from gerbil and rat (Zheng et al. 2000; Ludwig et al. 2001).  The human counterpart resides 
in chromosome 7, but remains to be cloned (Zheng et al. 2000).  SLC26A5 acts as a new type of 
molecular motor in cochlea. It mediates changes in outer hair cell length in response to membrane 
potential variations, being responsible for sound amplification in the mammalian hearing organ.  
SLC26A5 uses monovalent anions as an extrinsic voltage sensor. After binding, these anions are 
translocated across the membrane in response to changes in the transmembrane voltage. This 
translocation triggers conformational changes in the protein that ultimately alters its surface area in 
the plane of the plasma membrane.  Interestingly, SLC26A5 functions as an incomplete transporter, 
since it swings anions across the cell membrane but does not allow them to dissociate and escape to 
the extracellular space. Furthermore, SLC26A5 functions at microsecond rates, which is much 
faster than any other cellular motor protein (Oliver et al. 2001).    
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In this study, in addition to SLC26A1, we have cloned and functionally characterized four novel 
anion exchangers in chromosomes 3, 8, 6 and 1, named SLC26A6-A9, respectively. All four 
proteins showed distinct tissue-specific expression patterns, and functional expression demonstrated 
chloride, sulfate or oxalate transport activities.  The chromosomal loci and initial tissue distribution 
of SLC26A10 and A11 are known but the genes remain poorly characterized so far. The 
characterization of these novel members may provide clinically important new insights to anion 
transport physiology in different parts of body. 
 
Table 5. The SLC26 family of human anion exchangers. 
Gene symbol Chromosome 
location 
Major sites of 
expression 
Diseases Sequence 
accession  
SLC26A1 (SAT1) 4p16 Liver, pancreas, 
brain, kidney 
None AF297659 
SLC26A2 
(DTDST) 
5q32 Ubiquitous DTD, OMIM 222600 
ACGIB, OMIM 600972 
AOG2, OMIM 256050 
U14528 
SLC26A3  (CLD, 
DRA) 
7q22-q31.1 
 
 
Ileum, colon, 
seminal vesicle, 
eccrine sweat 
gland 
Congenital chloride 
diarrhoea, OMIM 
214700  
L02785   
 
SLC26A4 (PDS) 7q22-q31.1 Thyroid, kidney, 
cochlea 
Pendred syndrome, 
OMIM 274600 
AF030880   
SLC26A5 
(Prestin) 
7 Outer hair cells of 
the cochlea 
Not known AC005064, 
(AF230376 for  
gerbil) 
SLC26A6  3p21 Kidney, pancreas Not known AF279265  
  
SLC26A7 8q21 Kidney Not known AF331521 
SLC26A8 (Tat1) 6p21 Testis Not known AF331522 
SLC26A9 1q32 Lung Not known AF331525 
SLC26A10 12q14 Brain, other? Not known AF331523 
SLC26A11 17q25 Ubiquitous Not known AF331524 
 
 
The SLC26A6-A9 proteins are highly homologous to the previously known members, and 
comparison of the protein sequences revealed at least two common conserved domains within the 
family: sulfate transporter family and STAS domains (Table 4). The functional significance of these 
domains is still unclear. The STAS domain has been found from bacterial antisigma-factor 
antagonists (ASA) typified by Bacillus subtilis SPOIIAA and it has been found to express 
nucleotide binding activity (Najafi et al. 1996; Kovacs et al. 1998). Thus, the identification of the 
putative NTP-binding domain in the anion exchangers suggests that their function could be 
regulated by intracellular concentrations of GTP and/or ATP (Aravind and Koonin 2000).  The 
critical role of the STAS domain is further supported by a number of diseases causing mutations 
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mapped to this region in the SLC26A2-SLC26A4 genes (Hästbacka et al. 1994; Superti-Furga et al. 
1996; Everett et al. 1997; Höglund et al. 1998).   
  
Sequence analysis revealed also that many SLC26 family members have a consensus PDZ-binding 
domain at their C-terminus (Table 4).  The PDZ domain proteins play essential roles in maintaining 
the cell polarity and function by distributing receptors, transporters, ion channels and lipids 
asymmetrically between the apical and basolateral membranes (Fanning and Anderson 1999). Thus, 
the consensus PDZ motif found from the family members suggests that they could be regulated by 
PDZ-mediated interactions and supports the general concept of microdomain organization for ion 
transport. 
 
 
 
Figure 9. A phylogenetic analysis of SLC26 family in human, D melanogaster and C. elegans. 
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Phylogenetic analysis of the human, D. melanogaster and C. elegans family members illustrates the 
relationship of the exchangers with each other (Fig. 9).  The SLC26 family members are mainly 
divided to three separate groups according to species. However, the human SLC26A1 and 
SLC26A2 proteins separate to their own branch.  Structurally these two proteins resemble each 
other most, and their genomic structures are also very similar with three to four exons, which differs 
from the other human members consisting of about 20 exons. Diverging exon structure of 
SLC26A1 and A2 suggests that they may have lost most of their introns during evolution and 
resulted from a duplication event, although they have different chromosomal locations at 5q32 and 
4p16, respectively. A similar but more recent duplication event has been suggested for the 
SLC26A3 and A4 genes, which reside within 40 kb of each other in chromosome 7 (Everett et al. 
1997).   
 
6.2. The novel SLC26 family members may have important tissue-specific functions 
A striking feature of SLC26 family is the tissue-specificity of its members. The distribution of 
SLC26A3 and SLC26A4 is specific for the affected organs in congenital chloride diarrhoea and 
Pendred syndrome, respectively (Höglund et al. 1996; Everett et al. 1997). Functionally, the 
SLC26A3 protein is a major Cl-/HCO3- exchanger in the gut and transports at least sulfate, oxalate 
and hydroxyl as well (Silberg et al. 1995; Melvin et al. 1999; Moseley et al. 1999), whereas 
SLC26A4 transports at least iodide, chloride and formate, but not sulfate (Scott and Karniski 2000).  
SLC26A2 expression is not restricted to the affected cartilage, but it can be found from many other 
tissues as well (Hästbacka et al. 1994; Haila et al. 2001). SLC26A5 is expressed only in the outer 
hair cells of the cochlea (Zheng et al. 2000). SLC26A6 is widely expressed, but at highest levels in 
kidney and pancreas. Consistently, the SLC26A7-A9 genes showed highly restricted expression 
patterns in kidney, testis and lung, respectively. Thus the tissue-specific expression likely points to 
important roles for the new members in these organs.    
 
Several lines of evidence suggest SLC26A6 as a good candidate for a pancreatic ductal anion 
exchanger with a major physiological function. The primary function of the apical epithelium of the 
pancreatic duct is to secrete HCO3- anions (Gray et al. 1989). In pancreatic duct secretions from 
cystic fibrosis (CF) patients the HCO3- concentration is markedly reduced (Gaskin et al. 1982), and 
intraductal pH is sufficiently altered to precipitate proteins secreted from acinar cells (Freedman et 
al. 1998). In the currently accepted model of HCO3- secretion, the defect in secretion lies at the 
apical membrane of the ductal cells, where decreased secretion of Cl- via CFTR inhibits the apical 
Cl-/HCO3- exchanger. Recent studies suggest that the stimulation of CFTR selectively results in 
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activation of luminal Cl-/HCO3- exchange activity in pancreatic ducts of mice and probably in other 
CFTR expressing cells (Lee et al. 1999).  Furthermore, Cl-/HCO3- exchange activity has been found 
in the basolateral and luminal membranes of mouse pancreatic ducts (Zhao et al. 1994; Zhao et al. 
1995), but the protein responsible for luminal Cl-/HCO3- activity has not been identified yet.   
 
SLC26A6 protein was located to the apical and basolateral surfaces of tubular walls of human 
kidney and the apical surfaces of ductal pancreas and all SLC26A6 isoforms were expressed in a 
pancreatic ductal cell line, Capan-1. The high structural homology of SLC26A6 to known family 
members (SLC26A1-A5), which all transport Cl- and HCO3- anions and demonstration of chloride, 
sulfate and oxalate transport activities further support the idea of SLC26A6 as a novel Cl-/HCO3- 
exchanger. Finally, a recent study demonstrated that SLC26A6 indeed functions as a DIDS-
sensitive Cl-/HCO3- exchanger when expressed in Xenopus laevis oocytes (Wang et al. 2002). 
 
The expression pattern and substrate specificity of the mouse slc26a6 proposes that it mediate 
several modes of anion exchange in a number of tissues, supporting our observations.  Recently, a 
putative mouse orthologue of human SLC26A6, CFEX, (chloride-formate exchanger), was 
localized to the brush border membrane of renal proximal tubule cells and was demonstrated to 
mediate Cl- -formate exchange when expressed in Xenopus oocytes (Knauf et al. 2001).  Further 
examinations of different anions demonstrated that mouse slc26a6 has affinity for oxalate, sulfate 
and bicarbonate in addition to chloride and formate (Jiang et al. 2002).  Mouse Slc26a6 can also 
function in multiple exchange modes involving pairs of these different anions, sharing the ability to 
mediate Cl- -base exchange with slc26a3 and slc26a4 (Melvin et al. 1999; Soleimani et al. 2001; 
Jiang et al. 2002; Xie et al. 2002).  Interestingly, the mouse slc26a6-mediated Cl-/HCO3- and Cl-
/oxalate exchange elicits simultaneous membrane hyperpolarization, suggesting that it is an 
electrogenic transporter (Jiang et al. 2002; Xie et al. 2002).   
 
Our results support also the general concept of microdomain organization for ion transport, and 
suggest a mechanism for CFTR-mediated SLC26A6 upregulation in pancreatic duct cells (Fig. 12). 
Recently, CFTR has been found to be necessary for the cAMP inhibition of HCO3- salvage, which 
is mediated by SLC9A3 and a yet unidentified Na+ -dependent system. This regulatory interaction 
is mediated by binding of CFTR to PDZ1 and NHE3 to PDZ2 of NHERF (also known as EBP50) 
(Ahn et al. 2001). Therefore, our results, showing the interaction of SLC26A6 with PDZ1-2 
domains of NHERF and E3KARP, suggest a similar regulatory mechanism for CFTR-directed 
luminal HCO3- secretion involving a CFTR-SLC26A6-NHERF complex. Upon pancreatic cell 
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stimulation, a complex of CFTR, NHERF (or E3KARP) and SLC26A6 might be assembled (or a 
pre-existing complex might be activated or modified) to stimulate HCO3- secretion, while the 
CFTR-NHERF-NHE3 complex inhibits HCO3- salvage (Fig. 10).  This model is further supported 
by observations that CFTR induces the expression of SLC9A3, SLC26A3 and SLC26A6 (Ahn et al. 
2001; Greeley et al. 2001).  However, this model requires refinements and the exact composition of 
a putative multiprotein complex of NHERF or E3KARP, SLC26A6 and possibly CFTR or other 
proteins remains to be determined.   
With regard to SLC26A6 and SLC26A6c (which carry the PDZ interaction motif) and SLC26A6d 
(which does not have the PDZ interaction motif) further studies will be needed to address the 
functional significance of the PDZ domain interaction motif for apical plasma membrane targeting 
and modulation of transport activity in polarised cells. PDZ interaction appears to be important, but 
not sufficient for targeting of CFTR to or retention of CFTR in the apical membrane in polarized 
cells (Short et al. 1998; Moyer et al. 2000). Interestingly, it has been observed that the binding of 
PDZ domain proteins to CFTR has a direct potentiating effect on channel activity (Wang et al. 
2000; Raghuram et al. 2001). However, despite a number of studies the functional role of the PDZ 
interaction motif of CFTR remains somewhat unclear.  
 
-PDZ 
SL
 
Figure 10. SLC26A6 may f
the pancreatic duct. CFTR
mediated protein-protein inte
  
C26A6? 
unction as CFTR-directed Cl-/HCO3- exchanger in the luminal side of 
-mediated regulation of SLC26A6 may be controlled through PDZ 
ractions (modified from Ahn et al. 2001). 
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SLC26A6 and A7 are likely to play roles in the maintenance of the electrolyte and acid-base 
homeostasis in human kidney.  SLC26A6 was localized to proximal and distal tubules and 
SLC26A7 specifically to the distal tubules, suggesting their cell type-specific anion transport 
functions in these nephron segments.  The kidney is the major organ responsible for maintaining 
electrolyte balance and acid-base homeostasis in mammals. This is accomplished mainly by 
absorption of NaCl and secretion of acid or base equivalents in different segments of the nephron 
(Alpern et al. 1991). Functional studies using perfused tubules and isolated brush border vesicles 
have led to the concept that a major fraction of Cl- entry across the apical membrane of proximal 
tubule cells occurs via Cl-/formate and Cl-/oxalate exchanges (Aronson and Giebisch 1997). 
However, although functional studies have characterized many of these transporters, their molecular 
identities have remained largely unknown, and still unknown acid-base transporters are likely to 
exist (Wang et al. 1993; Tsuruoka and Schwartz 1999; Soleimani et al. 2001).  
 
Furthermore, defects in some of the renal transport systems have been associated with different 
diseases such as autosomal dominant and recessive distal renal tubular acidosis. The dominant form 
has been associated with mutations in the basolateral SLC4A1 (Bruce et al. 1997), and in addition 
to two known loci, ATB6B1 and rdRTA2, yet further unknown loci are suggested (Karet et al. 
1998; Karet 1999; Karet et al. 1999). Therefore, further studies regarding the function and 
expression of the SLC26A6 and -A7 proteins in different renal pathophysological states are clearly 
warranted.   
 
SLC26A7 expression was observed also in HEV cells (Vincourt et al. 2002). HEVEC are known to 
incorporate large amounts of inorganic sulfate, and sulfate residues are essential for the recognition 
of HEVEC sialomucins by L-selectin, a cell adhesion molecule that mediates the initial interaction 
of lymphocytes with HEVEC (Girard and Springer 1995; Vincourt et al. 2002).  Previously, 
SLC26A2 and a novel sodium-dependent sulfate transporter, SLC13A4, have been proposed to 
mediate the sulfate uptake into human HEVEC (Girard et al. 1999).  Our demonstration of the 
sulfate transport function of SLC26A7 suggests a possible cooperative role in sulfation of HEV 
sialomucins and regulation of lymphocyte migration in organized lymphoid tissues at sites of 
chronic inflammation.  
 
The testis is composed of loops of seminiferous tubules lined with epithelium containing Sertoli 
cells and spermatogenic cells at various stages of differentiation. The seminiferous tubule fluid 
establishes the microenvironment for spermatogenesis and transports spermatozoa from the tubules 
 65
     
to the head of the epididymis.  The specific composition of the fluid produced by the Sertoli cells 
may play a vital role in germ cell development (Tuck et al. 1970). The germ cell-specific expression 
of SLC26A8 suggests a functional role in these cells. The extensive morphological changes 
observed during spermatogenesis suggest that the regulation of ion transport is a critical component 
of this differentiation process.  
 
SLC26A8 expression was limited to the meiotic phase of the development, since strong staining 
was seen only in the spermatocytes and developing spermatids. Because SLC26A8 demonstrated 
chloride, sulfate and oxalate transport activities, our results suggest its function as a novel male 
germ cell-specific anion exchanger, which may be directly required for the development and 
maturation of these lineages. Specifically, sulfate transport may play an important role for germ cell 
development, as observed previously for the development of the cartilage in DTD patients 
(Hästbacka et al. 1994). Moreover, SLC26A8 has been linked to RhoGTPase signaling, which plays 
an important role in the development and function of male germ cells (Toure et al. 2001). Finally, 
SLC26A8 function may also affect the composition of the seminal fluid and participate in the 
regulation of the Sertoli cells. Of importance, failure of spermatogenesis has recently been 
associated with impaired transport function in mouse deficient of the Na+-K+-2Cl- cotransporter 
(Pace et al. 2000). Thus, defective function of SLC26A8 might also result in impaired 
spermatogenesis, making the gene a plausible candidate for male infertility.   
 
Functional characterization of SLC26A9 as a DIDS-sensitive anion exchanger may cast more light 
into the anion transport physiology of human lung. Airway epithelia is involved in both fluid and 
electrolyte absorption and secretion. Various mechanisms involving Na+ and Cl- transport have 
been identified, including electrogenic Na+ and Cl- channels, and electroneutral Na+/H+ exchange 
and Cl-/HCO3- exchange (Welsh 1987; Tse et al. 1993; Voilley et al. 1993; Alper 1994; Yun et al. 
1995).  SLC4A2 and A3 anion exchangers have been found in human airways (Dudeja et al. 1999; 
Loffing et al. 2000). Although detailed functional roles of SLC26A9 remain to be defined, its 
expression in the bronchial and alveolar cells of distal lung suggest a role in the maintenance of 
intracellular pH of the epithelial airway cells and possibly also the pH of airway surface liquid.  The 
distal airways including medium and small terminal bronchioles cover >80% of the total mucus 
membrane surface area of the conducting airways, and play a pivotal role in formation and 
regulation of airway secretion (Boucher 1994).    
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The regulation of ion transport and the composition of ASL are important parts of lung defence 
mechanisms and may contribute to different airway diseases (Noone et al. 1994).  Recent studies 
suggest that the composition of ASL is regulated by active ion transport systems (Tarran et al. 
2001). In cystic fibrosis, defective secretion of chloride and hence excessive ASL absorption results 
in a characteristic syndrome with retained secretions, bacterial infection, and lung destruction 
(Sferra and Collins 1993). Conversely, pseudohypoaldosteronism patients, who exhibit loss-of-
function mutations in ENaC, have an excess of ASL due to reduced Na+ absorption.  This leads to 
drastic acceleration of the mucus transport (Kerem et al. 1999).  SLC26A9 may participate in the 
regulation of volume and composition of the ASL as well as in the sulfation of the mucosal 
components, and its defects in transport function may associate with diseases of the human 
respiratory system.  
 
6.3. Altered expression of transporters may contribute to diarrhoea in intestinal inflammation 
The main function of the human colon is to absorb about 90% of over 2 litres of Na+- and Cl--rich 
fluid, which passes daily through the small intestine (Debongnie and Phillips 1978).  In normal 
colonic mucosa, the rates of salt and water absorption are directly related, and the main factor 
determining the extent of water movement out of the colonic lumen is the rate of Na+ absorption 
(Binder and Sandle 1994). The human colon possesses an array of Na+ absorptive mechanisms that 
are not distributed uniformly throughout its length. Much of the Na+ absorption is mediated by 
electroneutral pH-coupled Na+/H+ and Cl-/HCO-3 exchangers (Knickelbein et al. 1985). However, 
there are also apical sodium channels, which are involved in electrogenic sodium transport (Canessa 
et al. 1994). Instead, CFTR seems to be the only pathway for Cl- exit in the colonic epithelium 
(Mall et al. 1998).   
 
CFTR have been shown to play a central role in coordinating electrolyte transport in various tissues 
including the intestines, pancreas, lungs, sweat glands, and kidneys. CFTR is a member of the ATP-
binding cassette (ABC) membrane transporter superfamily (Riordan et al. 1989).  It contains 1480 
amino acids and consists of two homologous halves with six membrane-spanning segments and a 
nucleotide-binding domain.  The two halves of CFTR are linked by a cytoplasmic regulatory 
domain (R-domain) that contains a number of consensus phosphorylation sites (Riordan et al. 
1989).  CFTR forms a cAMP- and Ca2+-activated Cl- channel, which requires ATP hydrolysis for 
the channel to open and close (Gadsby and Nairn 1999). 
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Defects in CFTR expression or functions cause cystic fibrosis (CF, OMIM #219700) and a form of 
male sterility due to congenital bilateral absence of the vas deferens (De Braekeleer and Ferec 
1996). In contrast, overstimulation of Cl- secretion, e.g. by bacterial enterotoxins, is associated with 
secretory diarrhoea (Vaandrager et al. 1997).   CF presents defective fluid and electrolyte secretion 
in the respiratory, pancreatic, intestinal and genitourinary systems (Riordan et al. 1989; Pilewski 
and Frizzell 1999). The intestinal and lungal phenotypes of CF result from luminal obstruction by 
thick mucoid secretions (Eggermont and De Boeck 1991). In pancreatic duct secretions from CF 
patients the HCO3- concentration is markedly reduced (Gaskin et al. 1982), and intraductal pH is 
sufficiently altered to precipitate proteins secreted from acinar cells (Freedman et al. 1998). The 
defect in secretion lies at the apical membrane of the ductal cells, where defective CFTR inhibits 
the apical Cl- /HCO3- exchanger. 
 
The function of the colonic epithelium includes the regulation of water and ion transport as well as 
the formation of an effective barrier against the invasion of noxious agents and antigens.  Both 
functions seem to be impaired in ulcerative colitis, leading to intestinal inflammation and diarrhoea 
in the course of disease. The pathophysiological mechanisms of diarrhoea in UC are not completely 
known, although various investigations have been made concerning the contributory role of the 
activation of secretion (Rampton and Laden 1984), the reduction of ion absorption (Harris and 
Shields 1970; Rask-Madsen 1973), and a defect in epithelial barrier function (Sandle et al. 1990).  
 
To understand better the pathophysiology of diarrhoea in UC, we examined the effect of intestinal 
inflammation on the expression of three intestinal electrolyte transporter genes, suggested to 
account for the major colonic NaCl and fluid movements: SLC26A3, SLC9A3 and CFTR.  Further 
interest in these genes is stimulated by the fact that their functional defects have been associated 
with diarrhoeal diseases such as congenital chloride diarrhoea and sodium diarrhoea; and a distinct 
phenotype with lack of secretory response and meconium ileus seen in cystic fibrosis (Guerrant et 
al. 1990; Schultheis et al. 1998; Kere et al. 1999). In addition, the CFTR-induced upregulation of 
the SLC26A3 and SLC9A3 mRNA expression in heterologous systems supports the idea that the 
three proteins work in concert with each other (Wheat et al. 2000; Ahn et al. 2001; Greeley et al. 
2001).  Thus, defects in any of these proteins may affect the expression and function of the others as 
observed with the SLC9A3 knockout mice demonstrating the upregulation of the SLC26A3 gene 
(Melvin et al. 1999). 
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Although CFTR has a crucial role in the regulation of the intestinal electrolyte homeostasis, not 
much is known about its expression or function in inflamed colon mucosa. In general, inflammatory 
stimulation results both in an increased epithelial permeability and altered patterns of proliferation 
and differentiation of intestinal epithelial cells (Madara and Stafford 1989; Ziambaras et al. 1996). 
Elevated CFTR expression and enhanced cAMP-dependent Cl- secretion have been demonstrated in 
hyperproliferated mouse intestine (Umar et al. 2000). In addition to Cl- secretion, CFTR has been 
shown to regulate the function and properties of Na+ and K+ channels, the Cl-/HCO-3 exchanger, 
Na+/H+ exchanger, mucous secretion and, secondarily, water permeability (Kunzelmann et al. 
2000). Thus, the upregulation of CFTR, as shown in our series of inflamed tissues, might result in 
both increased secretion of Cl- and decreased absorption of sodium of the mucosa, and ultimately 
contribute to diarrhoea. 
 
Previous studies have produced ambiguous results demonstrating decreased or unchanged CFTR 
expression in intestinal epithelium (Madara and Stafford 1989; Besancon et al. 1994; Colgan et al. 
1994). In our study, the expression of the CFTR protein was detected both in healthy and inflamed 
colon mucosa by immunohistochemistry, although the overall expression level of CFTR in colon is 
not abundant. Interestingly, some inflamed colon tissue samples demonstrated cytoplasmic 
expression of CFTR that could not be detected in normal control. It corresponds likely to a newly 
synthesized or retarded form of the CFTR protein in intracellular compartments, and might suggest 
that the translation of the CFTR protein is enhanced in the inflamed colon mucosa.  
 
Both the activation of ion secretion and the reduction of ion absorption have been suggested as the 
pathomechanisms in diarrhoea in UC.  The inflamed colonic mucosa contains increased levels of 
different inflammatory mediators, which are capable of triggering Cl- secretion.  The secretion of 
chloride and accompanying secretion of water are thought to be important transport abnormalities 
contributing to the pathogenesis of diarrhoea in UC (Wardle et al. 1993; Wardle and Turnberg 
1994).  However, there is also a limited number of human studies as well as animal models of 
colitis supporting the idea that diarrhoea in IBD is likely due to anti-absorptive rather than pro-
secretory effects (Greig and Sandle 2000).  The high lumen-negative transmucosal electrical 
potential difference present in normal colon is decreased in UC patients, suggesting loss of 
electrogenic Na+ absorption rather than enhanced Cl- secretion (Sandle et al. 1986; Sandle et al. 
1990).  In addition, malabsorption of Na+ and Cl- has also been associated with inflamed colonic 
mucosa (Harris and Shields 1970; Edmonds and Pilcher 1973; Hawker et al. 1980; Bell et al. 1995; 
Sundaram and West 1997) as well as a notably diminished activity of basolateral membrane Na+-
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K+-ATPase, which is a prerequisite for apical Cl- secretion (Sandle et al. 1990). These studies 
indicate that impaired water absorption secondary to impaired Na+ and Cl- absorption rather than Cl- 
secretion is a major pathogenic factor in the diarrhoea of acute colitis. Therefore, further studies are 
still required to correlate the putative functional changes in inflamed human colon with the elevated 
level of CFTR and its putative intracellular redistribution found in this study.   
 
This study supports our earlier findings demonstrating similar expression of the SLC26A3 mRNA 
in inflammatory bowel disease and ischemic colitis when compared with normal colon epithelium 
(Haila et al. 2000).  In this study, there were no significant changes in the expression of the 
SLC26A3 and SLC9A3 genes in ulcerative colitis compared with non-inflamed tissues, when all 
subgroups were analysed together. However, there is variation in the individual levels of expression 
of the genes, especially with SLC9A3, which may reflect alterations in region-specific expression 
of the genes, because the tissue samples were collected at different locations along the colon. 
Furthermore, all the patients were treated with glucocorticosteroids known to alleviate intestinal 
inflammation and modulate the expression of some genes involved in transport processes; e.g., 
SLC9A3 (Ambuhl et al. 1999; Kiela et al. 2000). 
 
Characterization of the effect of disease activity on epithelial gene expression revealed slight 
changes for SLC26A3 and SLC9A3. An initial increase in mild disease was followed by a decrease 
in moderate and severe UC in the case of SLC26A3.  SLC9A3 expression increased more than that 
of SLC26A3 in mild UC, but remained unchanged in severe UC. Speculatively, the slight but 
insignificant increase in the expression of SLC26A3 and SLC9A3 in mildly inflamed intestine 
could also reflect an increased activation of CFTR as shown previously in other expression systems.  
There are several reasons that may be responsible for the reduction of the SLC26A3 mRNA seen in 
severe UC. It may be secondary, due to a loss of epithelial cells by erosions and ulceration, or due 
to an expansion of an undifferentiated crypt cell compartment.  However, no changes in the 
expression of the SLC26A3 protein was noted even in severe UC.  In our earlier study, we observed 
the expansion of the SLC26A3 expression deeper in the crypts to the cells of the proliferative cell 
compartment in a set of inflammatory colon samples (Haila et al. 2000).  Similarly, SLC9A3 
staining has been suggested to remain unchanged in a colon tissue specimen of an UC patient (Yang 
et al. 1998).  It is likely that the protein translation machinery in inflamed intestinal cells can 
compensate small fluctuation in the mRNA level.   
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A rabbit model of chronic ileal inflammation has demonstrated that the inhibition of coupled NaCl 
absorption by the villus cells occurs as a result of diminished Cl-/HCO-3 but not Na+/H+ exchange 
activity (Sundaram and West 1997).  The mechanism has been shown to be a decrease in affinity for 
Cl- rather than an altered number of transporters.  Since there were no significant changes in the 
levels of SLC26A3 and SLC9A3 transporters even in severe colitis, it is tempting to speculate that a 
similar model of inhibition of NaCl absorption might exist also in human colon.  However, several 
different studies using different conditions or models have produced ambiguous results regarding 
the regulation of the expression of different apical and basolateral transporters (Madara and Stafford 
1989; Sandle et al. 1990; Besancon et al. 1994; Colgan et al. 1994; Yang et al. 1998). Moreover, 
significant differences may occur in different models and there may be differences even between 
UC and other types of intestinal inflammation.   
 
In summary, intestinal inflammation modulates the expression of these major mediators of intestinal 
salt transport and may contribute to diarrhoea in ulcerative colitis both by increasing transepithelial 
Cl- secretion and by inhibiting the epithelial NaCl absorption, but a simple clear picture of a single 
mechanism has not emerged. 
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CONCLUSIONS AND FUTURE PROSPECTS
As an example of the fruits of genome projects, this study describes the expansion of the SLC26 
family using a genome-driven approach.  Subsequently, seven novel loci (designated SLC26A1, 
A6-A11) with distinct tissue expression patterns were identified and mapped, demonstrating the 
power of the genomic approach in the identification of new genes. The preliminary characterization 
of the structure, expression and function of the SLC26A6-A9 genes suggest that the novel members 
are likely to participate in important physiological functions involving anion transport in different 
organs and might associate with disorders.   
 
It is obvious that much work has to be done to define the cellular and molecular mechanisms 
underlying the function, expression and regulation of the new family members.  However, mapping, 
cloning and functional characterization of the new genes provide now a rich source for additional 
physiological studies. In addition, determination of the genomic structures enables the screening of 
possible mutations in diseases.  Characterization of new genes facilitates also the cloning of the 
orthologs from other species. More specifically, targeted disruption of the mouse orthologs would 
further help to understand the physiological roles of the new SLC26 family members in respective 
tissues.  
Several lines of evidence support the idea of SLC26A6 as a good candidate for a yet unknown, 
CFTR-regulated protein responsible for the luminal Cl-/HCO-3 exchange in pancreas. First, 
SLC26A6 is expressed in the apical surface of pancreatic ducts. Second, SLC26A6 and its two 
alternatively spliced variants demonstrated chloride transport activity. Third, the C-terminus of 
SLC26A6 interacted with the PDZ domains of the E3KARP and NHERF proteins in vitro.  
Recently, CFTR has been found to be necessary for the cAMP inhibition of HCO3- salvage 
mediated partly by SLC9A3 and this regulatory interaction is mediated by binding of CFTR to 
PDZ1 and NHE3 to PDZ2 of NHERF (Ahn et al. 2001). Thus, our results suggest a mechanism for 
CFTR-mediated SLC26A6 upregulation in pancreatic duct cells, and support the general concept of 
microdomain organization for ion transport.   
Although further studies are needed to refine this coarse model, our results suggest a clinically 
important role for SLC26A6 in pancreatic HCO3- metabolism. In pancreatic duct secretions from 
cystic fibrosis patients the HCO3- concentration is markedly reduced and intraductal pH is 
sufficiently altered to precipitate proteins secreted from acinar cells. The defect in HCO3- secretion 
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lies at the apical membrane of the ductal cells, where decreased secretion of Cl- via CFTR inhibits 
the apical Cl- /HCO3- exchanger.   
 
The first three human genes, SLC26A2-A4, associate with phenotypically different disorders, 
involving cartilage growth, gut absorption, and hearing, respectively.  Thus, the three closely related 
but highly tissue-specific human anion transporters play central roles in the etiology of 
phenotypically very different recessive diseases.  Similarly, the tissue-specific expression of 
SLC26A7-A9 in kidney, testis and lung, respectively, suggest important cell-specific anion 
transport functions. SLC26A7 localized to distal segments of nephrons, SLC26A8 to developing 
spermatocytes, and SLC26A9 to the lumenal side of the bronchiolar and alveolar epithelium of 
lung. Furthermore, all three proteins demonstrated chloride, sulfate and oxalate transport activity. 
Thus, SLC26A7 is likely to play a role in the maintenance of the electrolyte and acid-base 
homeostasis in human kidney. Defective function of SLC26A8 might result in impaired 
spermatogenesis, making the gene a possible candidate for male infertility. SLC26A9 may 
participate in the regulation of the airway surface liquid, which is an important part of the lung 
defence systems, and impaired function of SLC26A9 might associate with diseases of the human 
respiratory system. Therefore, further studies regarding the function and expression of the proteins 
in different pathophysological states are clearly warranted.   
 
In this study, as an example of the physiological role of ion transporters in pathophysiological 
states, we investigated how intestinal inflammation affects the expression of three major 
transporters of intestinal salt transport, namely SLC26A3 (Cl-/HCO3--exchanger), SLC9A3 
(Na+/H+-exchanger) and CFTR (Cl--channel), to understand the pathophysiology of diarrhoea in 
ulcerative colitis.  All three transporters are thought to play in concert with each other, and their 
functional defects have been associated with diarrhoeal diseases.  Our results indicate that intestinal 
inflammation modulates the expression of these major mediators of intestinal salt transport and may 
thus contribute to diarrhoea in ulcerative colitis both by increasing transepithelial Cl- secretion and 
by inhibiting the epithelial NaCl absorption. However, a simple clear picture of a single mechanism 
has not emerged and additional functional experiments are needed to understand better the 
pathophysiology of diarrhoea in inflammatory bowel diseases. 
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